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I  RISK OF ADVERSE HEALTH & PERFORMANCE EFFECTS OF 
CELESTIAL DUST EXPOSURE 
II  EXECUTIVE SUMMARY 
Crew members can be directly exposed to celestial dust in several ways. After crew 
members perform extravehicular activities (EVAs), they may introduce into the habitat dust that 
will have collected on spacesuits and boots. Cleaning of the suits between EVAs and changing of 
the Environmental Control Life Support System filters are other operations that could result in 
direct exposure to celestial dusts. In addition, if the spacesuits used in exploration missions 
abrade the skin, as current EVA suits have, then contact with these wounds would provide a 
source of exposure. Further, if celestial dusts gain access to a suit’s interior, as was the case 
during the Apollo missions, the dust could serve as an additional source of abrasions or enhance 
suit-induced injuries. When a crew leaves the surface of a celestial body and returns to 
microgravity, the dust that is introduced into the return vehicle will “float,” thus increasing the 
opportunity for ocular and respiratory injury. 
Because the features of the respirable fraction of lunar dusts indicate they could be toxic 
to humans, NASA conducted several studies utilizing lunar dust simulants and authentic lunar 
dust to determine the unique properties of lunar dust that affect physiology, assess the dermal 
and ocular irritancy of the dust, and establish a permissible exposure limit for episodic exposure 
to airborne lunar dust during missions that would involve no more than 6 months stay on the 
lunar surface. Studies, with authentic lunar soils from both highland (Apollo 16) and mare 
(Apollo17) regions demonstrated that the lunar soil is highly abrasive to a high fidelity model of 
human skin. Studies of lunar dust returned during the Apollo 14 mission from an area of the 
moon in which the soils were comprised of mineral constituents from both major geological 
regions (highlands and mares regions) demonstrated only minimal ocular irritancy, and 
pulmonary toxicity that was less than the highly toxic terrestrial crystalline silica (Permissible 
Exposure Limit [PEL] 0.05 mg/m3) but more toxic than the nuisance dust titanium dioxide 
(TiO2 [PEL 5.0 mg/m3]). A PEL for episodic exposure to airborne lunar dust during a six-month 
stay on the lunar surface was established, in consultation with an independent, extramural panel 
of expert pulmonary toxicologists, at 0.3 mg/m3. 
The PEL provided for lunar dust is limited to the conditions and exposure specified 
therefore additional research remains to be accomplished with lunar dust to further address the 
issues of activation, address other areas of more unique lunar geology (Glotch et al., 2010; 
Greenhagen et al., 2010), examine potential toxicological effects of inhaled or ingested dust upon 
other organ systems, such cardiovascular, nervous systems, and examine effects of acute 
exposure to massive doses of dust such as may occur during off-nominal situations. Work to 
support the establishment of PELs for Martian dust and dusts of asteroids remains to be 
accomplished. 
The literature that describes health effects of exposure to toxic terrestrial dusts provides 
substantial basis for concern that prolonged exposure to respirable celestial dust could be 
detrimental to human health. Celestial bodies where a substantial portion of the dust is in the 
respirable range or where the dusts have large reactive surface areas or contain transition metals 
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or volatile organics, represent greater risks of adverse effects from exposure to the dust. It is 
possible that in addition to adverse effects to the respiratory system, inhalation and ingestion of 
celestial dusts could pose risks to other systems. 
III  INTRODUCTION 
NASA has adopted a multi-destination human exploration strategy and is developing a 
core set of capabilities that will allow increasingly complex missions to near-Earth asteroids, the 
Moon, and Mars and its moons (NASA 2011). It is anticipated that a return to the Moon or 
missions to Mars will involve construction of habitats on the surface in order to support long-
duration human habitation and research. Therefore the potential opportunities for exposure of 
crews to celestial dusts, which could be returned to habitats after surface activities, would far 
exceed those occasioned by the limited number and duration of extravehicular activities (EVA) 
that occurred during the Apollo lunar landings. Therefore the risk of exposure to celestial dusts 
and the potential risk of adverse health effects will be elevated well beyond that experienced by 
the Apollo crews. During the Apollo missions, lunar dust, which had adhered to space suits 
during EVAs, gained entry to the interior of the lunar modules where, after becoming dislodged, 
it became airborne with the loss of lunar gravity upon ascent of the vehicle from the surface. The 
airborne dust irritated the eyes and throats of Apollo crews (Wagner, 2006). A flight surgeon, 
who was exposed to lunar dust during post-mission handling of EVA suits, reported symptoms 
consistent with an allergic response, which worsened with each exposure (Scheuring et al., 
2008). During the Apollo era, this anecdotal evidence of the possible toxicity of lunar dust was 
followed by an effort to experimentally assess its toxicity, but the effort produced little useful 
information because interpretation was complicated by spontaneous pathology in control animals 
(Holland and Simmonds, 1973). Later studies (Batsura, et al., 1981; Kustov et al., 1974 and 
1989) also suffered from limitations that compromised the quality of the toxicity assessments 
they provided. These assessments ranged from no effects (Kustov et al, 1974), when indices 
were assessed after animals were exposed to air that had passed over lunar dust, to findings of 
fibrosis after intratracheal instillation of massive amounts (50 mg) of dust (Kustov et al., 1989). 
Therefore at the time that new missions to the moon were being planned, the toxicity of lunar 
dust remained to be determined. 
The importance of particulates in air as a hazard to health has received increasing 
attention since the time of the Apollo missions. During the 1980s and ’90s, understanding of the 
mechanisms involved in the hazards posed to humans by exposures to the silicate mineral 
asbestos matured. There was tremendous concern when large-scale epidemiological studies, 
which had become feasible with advances in methods for processing large data sets, 
demonstrated the relationships between airborne particulate matter (PM) and impacts on human 
health (Bhatnagar, 2006; Cassee, 2007; Maynard, 2015). A substantial volume of research was 
begun that contributed to paradigms, which continue to evolve, that relate physiochemical 
characteristics of particulates to pulmonary toxicity. Prominent among the physiochemical 
features of mineral dusts that affect or may affect toxicity are size, morphology (shape, sharp 
edges, fractured surfaces, surface defects), surface area, surface reactivity, and solubility 
(Castranova et al.,1996; Donaldson and Borm 1998; Donaldson et al., 2001; Fenoglio et al., 
2000; Fubini 1998, 2002; Ghaizza et al., 2010; Gutherie, 1997; Jones and BéruBé 2007;  
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Kajiwara et al., 2007; Napierska et al., 2010; Ovrevik et al., 2005; Pauluhn 2011, 2012;  Sager et 
al., 2008; Schoonen et al., 2006; Schwarze et al., 2007; Warheit et al., 2006. 2007). 
Unlike Earth, on which atmospheric and water erosion of the surface has caused most 
rock to be formed by sedimentation, these processes are absent on the moon. Rather, the lunar 
rocks are volcanic in origin (igneous). The lunar surface is comprised principally of two 
geological regions, the mares and highlands regions. The mares region is composed of dark 
basalts, which form from rapid cooling of molten rock from massive lava flows. The highlands 
region is composed mostly of anorthosite that forms when igneous cools more slowly than 
basalts. These regions comprise 17 and 83%, respectively, of the exposed crust of the lunar 
surface. The vast majority of the mares are on the near side (Pieters, 1986). Evidence from the 
Lunar Reconnaissance Orbiter Diviner Lunar Radiometer Experiment revealed the presence of 
highly evolved, silica-rich lunar soils in kilometer-scale and larger exposures, which indicates 
that the moon has experienced a diverse set of igneous processes (Glotch et al., 2010; 
Greenhagen et al., 2010). Recent results, reviewed by Jaumann et al. (2012) also indicate OH- 
and H2O are formed and retained even outside of polar regions. H2O and OH- are thought to be 
formed “by solar wind protons interacting with oxygen-rich rock surfaces produced during 
micrometeorite impact on lunar soil particles” (Jaumann et al., 2012). 
Lunar regolith is the layer of unconsolidated rocks, pebbles, and dust over lunar bedrock 
(Colwell et al., 2007). Lunar dust, defined as particles less than 20 microns (µm) (Liu and 
Taylor, 2011) comprises about 20%, by weight of the lunar soil (Park et al., 2008). The 
respirable fraction of the dust (less than 2.5 µm) comprises 1-3% of the mass fraction of mature 
lunar soil (Cooper et al., 2010; McKay et al., 2015). Lunar dust possesses properties that have 
been associated with toxicity of mineral dusts. The native shape of lunar dust is a complicated 
morphology with glassy beads and irregular, sharp particles with extensive surface area (Liu et 
al., 2008). The surface of dust on the moon is likely to be reactive due to broken, dangling 
chemical bonds resulting from commutation due to micrometeoroid bombardment, proton 
bombardment from the solar wind, and ultraviolet and intergalactic radiation (Liu and Taylor, 
2011). Further, nanophase metallic iron (Fe0), which can catalyze the formation of hydroxyl 
radicals in solution via the Fenton reaction, is present in lunar dust particles (Taylor et al., 2001). 
The fraction of total iron present as Fe0 increases as the particle size diminishes (Taylor et al 
2011), at least as size decreases to 2 µm (McKay et al, 2015). These features suggested that lunar 
dust may be toxic. Data from recent studies in rodents (James et al., 2013; Lam et al., 2013) 
confirm that lunar dust is toxic to the respiratory system, but fortunately, these characteristics do 
not confer toxicity that exceeds that of quartz obtained here on Earth. 
Large portions of the surfaces of carbonaceous asteroids are covered in dust (Murdoch et 
al., 2015). On these celestial bodies the processes that operate on the lunar surface to produce 
dust and affect its properties (space weathering) are also effective and produce particles with 
rims containing Fe0 (Matsumoto et al., 2014). However, on asteroids of less than 1 km in 
diameter, dust produced by comminution resulting from micro meteor impacts likely attains 
escape velocities and is lost (Delbo et al., 2014). On these bodies thermal fatigue by temperature 
cycling is likely the more important process for dust formation (Delbo et al., 2014). On these 
small asteroids, vibrations from impacts, thermal fluctuations, and electrostatic lifting of surface 
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particles (Garcia et al., 2015; Renno and Kok, 2008) cause the smallest particles to migrate to 
gravitationally stable areas so that dust ponds, craters with flat floors filled with dust, result from 
migration of fine particles to low areas. Near sunset, oscillating canopies of dust will form over 
negatively charged craters on surfaces of airless bodies (Collier et al., 2012). On asteroids such 
as Vesta that are located where impact velocities of micrometeors are significantly less than they 
are at one astronomical unit from the sun (on the moon), shock dominates over melting and 
vaporization, and “regolith does not accumulate detectible nanophase opaque particles on rims of 
grains” (Pieters et al., 2012).  
On Mars, measurements made by the Spirit rover identified differences between the 
textures of surface and subsurface particles in Gusev crater. Wind alters the grain size 
distribution, angular shapes, and agglutinates caused by comminution in grains on the surface. 
Therefore, among grains ~ 100 µm (detection limit for Spirit), the agglutinates that are typical of 
lunar soils in this particle size range are absent, and most grains are rounded (McGlynn et al., 
2011). The fine-grained surficial dust, because of global mixing by wind (Yen et al., 2005), is 
very similar at the various landing sites (Schuerger et al., 2012). Indeed, “chemical analyses 
conducted with the Alpha Particle X-ray Spectrometer on the rover Curiosity corroborate the 
earlier compositional measurements of fine-grained wind-transported materials”, and confirm the 
remarkably homogeneous chemical composition of the dust (Downs, 2015).  It is highly oxidized 
and contains basaltic materials, nanophase iron oxides (npOx), and extremely high salts levels 
(e.g., MgCl2, NaCl, FeSO4, and MgSO4 [Morris et al., 2006]), high concentrations of heavy 
metals and perchlorate, and is likely acidic (Schuerger et al., 2012). The perchlorate content, 
which ranges between 0.5 and 1%, is 3 to 4 orders of magnitude greater than in soils on Earth 
(Davila et al., 2013). On Mars large-scale electrostatic fields generated by charged sand and dust 
in the dust devils and storms, as well as during normal saltation, can induce production of H2O2, 
which can condense, precipitate and be adsorbed into the regolith (Atreya et al., 2006). These 
features suggest that the Martian dust is likely toxic. 
Because evidence with which to assess the toxicity of lunar dust was unavailable when 
the planning of crewed missions to the moon was resumed in the last decade, NASA recognized 
a risk of adverse health effects associated with exposure to lunar dust and identified gaps in our 
knowledge about features of the dust and its toxicity that needed to be filled in order to establish 
safe exposure limits that would inform the design of habitats and vehicles so that exposures of 
crews to lunar dust would be limited to safe levels. Because the human exploration strategy now 
envisions multiple destinations, the scopes of these gaps have been extended beyond lunar dust 
to include the need to obtain evidence with which to assess the toxicity of dusts that will be 
encountered at other celestial destinations. 
IV  EVIDENCE 
A Spaceflight Evidence 
All spaceflight evidence pertaining to the effect of lunar dust on astronauts is anecdotal 
(Category III). The post-flight debriefing reports of the Apollo astronauts serve as a base of 
evidence (Armstrong et al., 1969; Cernan et al., 1973; Conrad et al, 1969; Scott et al., 1971; 
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Shepard et al., 1971; Young et al, 1972). In these reports, the Apollo crews provided several 
accounts of problems associated with their exposure to lunar dust. The following are excerpts 
from the reports of their debriefings: 
1. During Apollo 11, despite attempts by each astronaut to remove dust from his suit 
and equipment before entering the lunar module (LM) a large amount of lunar dust 
and grains was brought into the cabin. When the crew removed their helmets, they 
noticed a distinct, pungent odor, like that of gunpowder, emanating from the lunar 
material. Both crewmen discovered after they removed their helmets, overshoes, and 
gloves that they were very dirty. One grain of material got into the Commander's eye, 
but was easily removed and caused no problem. Crewmembers reported sleeping with 
their helmets on, in part, so they “wouldn’t be breathing all that dust” (Armstrong et 
al, 1969; Sheehan, 1975). The concern that particles remaining in the lunar module 
would float in the cabin atmosphere at zero-g after ascent caused the crew to wear 
their helmets to prevent eye and breathing contamination. Precautions were taken to 
prevent the command module (CM) from becoming contaminated with dust contained 
in the LM. Despite these precautions some dust entered the CM. The CM was cleaned 
during the return to earth at 24-hour intervals using the vacuum brush and towels. In 
addition, the circulation of the cabin atmosphere through the lithium hydroxide filters 
continued to remove traces of particulate material (Armstrong et al., 1969). 
2. During Apollo 12, the crew members reported that both LM and CM were 
contaminated with lunar dust; “The LM was filthy dirty and had so much dust that 
when I took my helmet off, I was almost blinded. Junk immediately got into my 
eyes”; and “[t]he whole thing was just a cloud of fine dust floating around in there.” 
After the LM docked to the CM, dust infiltrated the CM. Crewmembers gave the 
following account of this period of contamination: “On the way back in the CM the 
system could not handle the dust, so it was continuously spread inside the spacecraft 
by the system”; “[w]e chose to remain in the suit loop as much as possible because of 
the dust and debris floating around”; and “[t]o keep our eyes from burning and our 
noses from inhaling these small particles, we left our helmet sitting on top of our 
heads”;  “When you took your helmet off, you could smell the lunar dirt. It smelled 
like – the nearest analogy I can think of is gunpowder.” The dust was so fine that it 
was not removed by the filters “the system is not doing the cleaning, the dust is too 
fine” (Conrad et al., 1969). 
3. By contrast, the Apollo 14 crewmembers stated: “The cabin dust kind of swirled 
around. A lot of that went out through the relief valve at that point, which might have 
reduced it somewhat”. Dust was not a problem for us in the cabin”; and the dust 
control procedures were effective; we got very little dust back in the command 
module; I thought the command module was remarkably clean”; “there was no loose 
dust coming off the suits”; “We felt the procedures… certainly reduced the dust to a 
minimum” (Shepard et al., 1971). (It should be noted, however, that in the Apollo 14 
mission the crew did not experience any interference by dust with visualization of the 
surface during approach as was the case in earlier and later missions. This may have 
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been due in part to the Apollo 14 landing site being intrinsically less dusty than other 
Apollo landing sites, (Shepard et al., 1971)).   
4. The Apollo 15 crewmembers stated: “Our legs from about thigh down were just about 
completely covered with dirt”; “Cabin smelled like gunpowder when we first 
came into LM from EVA”; “you could see particulate matter floating around”; the 
vacuum cleaner did a good job of clearing the dust from the LM”; “When we woke 
up the next morning, I was surprised how clean the spacecraft was. I think most of the 
dust had been removed”; “Yes, the ECS (Environmental Control System) does a 
pretty good job of cleaning the place out. The smell was gone” (Scott et al., 1971). 
5. Apollo 16 crewmembers provided the following accounts: “The LM was extremely 
clean until the first EVA and then it was extremely dirty”; “I question whether the 
vacuum cleaner ever worked properly”; and “I thought it was quite a hazard over 
there floating through the LM with all the dust and debris. A number of times I got 
my eyes full of dust and particles. I felt like my right eye was scratched slightly once” 
(Young et al., 1972; Wagner, 2006). 
6. The Apollo 17 crewmembers recalled: “After the first EVA, we found out what the 
dust problem really was”; “Really, the dust was so deep and soft...”; “Probably the 
most difficult job of all the closeouts was trying to dust the suits”; “I had the sinus 
irritation on the surface”; “As soon as we were hard docked, the commander took off 
his helmet”. “…because of the dust debris in the LM spacecraft, I’m sorry I did. I 
could have left the helmet on, and I would have had a lot less eye and mouth type of 
irritation”. “You knew [that] you were in a very heavily infiltrated atmosphere in the 
LM because of the lunar dust”; “[t]he dust clearing was remarkable considering the 
amount of dust we had”; “[a]lthough there was a lot of irritation to my sinuses and 
nostrils soon after taking the helmet off, by 2 hours that had decreased considerably”; 
“I did all the transfer with my helmet off and I am sorry I did because the dust really 
bothered my eyes and throat. I was tasting it and eating it”; and “[w]hen I climbed in 
the tunnel I could tell there was a lot of dust in the LM and you could smell it” 
(Cernan et al., 1973). “You have to live with it but you're continually fighting the dust 
problem both outside and inside the spacecraft. Once you get inside the spacecraft, as 
much as you dust yourself, you start taking off the suits and you have dust on your 
hands and your face and you're walking in it. You can be as careful in cleaning up as 
you want to, but it just sort of inhabits every nook and cranny in the spacecraft and 
every pore in your skin. Although I didn't have any respiratory problems, I think the 
LMP (lunar module pilot) which he can comment on later, had some definite local 
respiratory problem immediately after the EVAs due to the dust in the cabin”. 
“Almost immediately upon removing my helmet, I started to pick up the symptoms 
that you might associate with hay fever symptoms. I never had runny eyes or runny 
nose. It was merely a stuffiness in the nose and maybe in the frontal sinuses that 
affected my speech and my respiration considerably. After about 2 hours within the 
cabin, those symptoms gradually disappeared. By morning of the next day, they were 
gone completely. After the second and third EVAs, although I'm sure the dust was 
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comparable, the symptoms were not nearly as strong as after the first EVA. That was 
as if I either developed a mucous protection of the affected areas or had some way or 
another very quickly developed an immunity to the effects of the dust” (Cernan et al., 
1973). 
Although no substantive evidence exists that astronaut performance was impaired by 
lunar dust (Wagner, 2006), one can imagine that if a crew member were “almost blinded” and 
had to “remain in the suit loop as much as possible because of the dust and debris floating 
around,” the dust did have some impact on performance. 
Dust from the lunar soil that was carried into the spacecraft during the Apollo missions 
proved to be a significant, intermittent problem. With the return to the moon and planned long-
duration stays on the lunar surface, contamination problems and toxicity of the dust are 
potentially much more serious than those that were experienced during the Apollo missions. 
Gravity at one-sixth that of the gravitational force of the Earth increases the time in which dust 
remains airborne, thereby increasing the probability that these dust particles will be inhaled. 
Some examples of lunar dust grains are provided in Figure 1. 
 
 
Figure	  1.	  Examples	  of	  lunar	  dust	  grains.	  –	  LEFT:	  Scanning	  electron	  microscope	  (SEM)	  image	  of	  a	  typical	  lunar	  agglutinate.	  Note	  the	  sharp	  
edges,	  reentrant	  surfaces,	  and	  microcraters.	  Smaller	  grains,	  which	  are	  less	  than	  1	  µm	  in	  diameter,	  are	  attached	  to	  this	  particle,	  and	  are	  also	  
seen	  as	  loose	  grains	  in	  the	  upper	  portion	  of	  the	  image.	  RIGHT:	  SEM	  image	  of	  a	  lunar	  agglutinate	  fragment	  that	  was	  removed	  from	  the	  outer	  
surface	  of	  Harrison	  Schmitt’s	  EVA	  suit.	  	  
B Ground-based Evidence 
Humans are typically exposed to respirable dust “of minerals and geomaterials during 
activities such as mining, quarrying, and sandblasting, building demolition, and natural processes 
such as volcanic ash eruption and dust storms” (Hurowitz et al., 2007). Ground-based evidence 
includes data that are derived from people who are exposed occupationally to mineral dusts in 
industrial settings, from people who live in close proximity to active volcanoes and have been 
exposed to volcanic ash, people who have live in regions exposed to windborne dusts from 
deserts, and from controlled laboratory experiments performed with humans, animals and cells. 
Mechanistic insights also guide our thinking concerning the potential toxicity of celestial dusts.  
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1. Evidence from Human Exposures during Industrial Operations 
Workers in the mining industry are often exposed to dust from freshly fractured mineral 
deposits. When these workers do not utilize respiratory protection or use inadequate protection 
the consequences are devastating. A prime example of this is the Hawks Nest mining disaster 
that occurred in West Virginia. In 1927, during the boring of a tunnel, deposits of silica were 
identified and mined; however, the workers did not use respiratory protection during the 
operations. Estimates of the proportion of workers who died, many within a few years of the 
exposure, are typically about 30% of the 2000 exposed workers (Cherniack, 1986). Silicosis has 
also caused fatalities among sandblasters (Abraham and Wiesenfeld, 1997). This rapidly lethal 
form of silicosis, “acute silicosis,” is characterized by alveolar proteinosis and interstitial 
inflammation (Driscoll and Guthrie, 1997). The respiratory effects are not exactly like those one 
would expect from simple or chronic silicosis, a disease that usually requires decades to develop 
after prolonged exposure to lower concentrations of silica dust. The latter disease is characterized 
by silicotic nodules that are clearly distinct from surrounding tissue and often surrounded by an 
inflammatory response (Driscoll and Guthrie, 1997).  
In addition to increased risk of silicosis, individuals with detectable exposure to 
crystalline silica (CS) were found by Calvert (Calvert et al., 2003) to have significantly increased 
risk for silicosis, chronic obstructive pulmonary disease, pulmonary tuberculosis, and rheumatoid 
arthritis. Although the International Agency for Research on Cancer released a monograph in 
1997 (IRAC 1997) that classified crystalline silica as a carcinogen, the dose-risk relationship, 
pathogenic mechanisms and the carcinogenic role of silica per se in absence of silicosis remains 
unclear (Erren et al., 2009; Pelucchi et al., 2006). However, substantial empirical evidence 
reviewed by Cox et al. (2011) supports an exposure-response relation between CS and risk of 
chronic inflammation, silicosis, fibrosis, and lung cancer, in a scenario in which exposures 
provoke inflammation, which produces increased reactive oxygen species (ROS) and reactive 
nitrogen species (RNS), pro-inflammatory mediators such as TNF-alpha, and eventual damage to 
lung tissue and epithelial hyperplasia, resulting in fibrosis and increased lung cancer risk among 
silicotics.  
2. Evidence from Animal and Human Exposure to Urban Air Pollution 
Urban air pollution is comprised of a mixture of contaminants. These include PM, ozone, 
carbon monoxide, nitrous oxides, sulfur oxides, heavy metals like lead and mercury, polycyclic 
aromatic hydrocarbons, and toxic chemicals. PM is a mixture of solid particles and liquid 
droplets that vary in size, shape, surface area, chemical composition, solubility and origin (Pope 
and Dockery, 2006). The size distribution of PM in air is trimodal within aerodynamic size 
ranges that are related to inhalation and depth of penetration within the respiratory system. 
Coarse particles, having aerodynamic diameters 10 – 2.5 µm (PM10 – PM 2.5), are derived 
primarily from dusts of soil, crustal materials, produced by farming, mining, windstorms, 
volcanos, as well as sea salts, pollen, mold, and spores. Fine particles (PM2.5 – PM0.1) are 
derived primarily from abrasive wear from tires and brakes, combustion processes, industrial 
processes, (e.g., smelters, cement plants, paper mills, and steel mills), and sulfate and nitrate 
particles generated by conversion from primary sulfur and nitrogen oxide emissions and 
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secondary organic aerosol from volatile organic compound emissions (Gasser et al., 2009; Pope 
and Dockery, 2006; Schettler, 2005). Ultrafine or nanoparticles are those with aerodynamic 
diameter < 0.1 µm (PM0.1). They are derived from abrasive wear from tires and brakes, 
combustion sources and atmospheric photochemical reactions and usually persist for minutes to 
hours before coagulating or condensing to form larger complex aggregates in the range of fine 
particles (Gasser et al., 2009; Pope and Dockery, 2006; Schettler, 2005). 
Shins et al. (2004) found PM10 from a rural setting produced greater inflammatory 
effects in rat lungs than PM2.5 from an industrial area and attributed the response to endotoxins 
or related contaminants. Others, however, have demonstrated that coarse particles have a 
toxicological capacity equivalent to fine particles on a mass basis (Sandstrom et al., 2005). The 
oxidative reactivity (OR) of size segregated PM was tested at a traffic site (Price et al., 2014). 
PM2.5 and PM0.1 caused more DNA damage than coarse PM10. PM exhibited more OR 
compared to manufactured carbon black particles. Size, surface area and metals (Zn and Fe) are 
important particle characteristics for OR (Price et al., 2014; Verma et al., 2010). On the other 
hand, Miller et al. (2012) claim that unpublished data demonstrate that “clean carbon particles 
with significantly lower levels of the surface chemicals and metals can generate similar, if not 
greater, levels of free radicals than that of urban particulates of a similar size”. Miller et al., 
(2012) argue that surface components alone may not be able to predict the toxicity of different 
PM and that in biological systems PM induce the cells/tissues to synthesize biologically-derived 
free radicals, adding to that produced directly by PM. There are several mechanisms by which 
different components of PM can generate free radicals and contribute to oxidative stress in 
biological systems. The pathways underlying effects on the cardiovascular (CV) system are 
complex and remain to be fully elucidated; however, PM-induced oxidative stress (Ayres et al., 
2008; Donaldson et al., 2013; Miller et al., 2012), and local and systemic inflammation 
(Donaldson et al., 2013) repeatedly emerge as potential mechanisms in all detrimental effects of 
PM on the CV system. Therefore, although the particulate constituents of urban air pollution are 
largely derived from anthropogenic sources, while those of celestial dusts are naturally 
occurring, the relevance of the finding of studies of the former to assessments of toxicity of the 
latter is to direct attention to features of celestial dusts that indicate that they may induce 
oxidative stress and inflammation. Indeed, Rowe (2000, 2007, 2013) suggested that exposure to 
lunar dust, in susceptible individuals, may lead to cardiovascular effects that are similar to those 
produced through exposure to air pollution.  
3. Evidence from Humans and Laboratory Animals Exposed to Volcanic Ash 
Volcanic ash originates from processes resulting in explosive eruptions into the 
atmosphere or pyroclastic flows from the surface and discharging ash as they cool, or some 
combination thereof. Basic (e.g. basaltic) eruptions produce no crystalline silica (e.g., quartz), 
and contain mafic minerals such as calcium-rich feldspar, pyroxenes and olivine, whereas acidic 
(e.g. rhyolitic) eruptions produce silica-rich (> 69% wt) ash with high concentrations of felsic 
minerals such as quartz, potassium-rich feldspar and silica glass (Derbyshire et al., 2012). The 
particle size, mineral composition, and form of the minerals vary considerably from volcano to 
volcano as well as from one eruption to another eruption of the same volcano. Analysis of 63 ash 
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samples from around the world showed that the fraction <4 µm varied from 0–17 vol% (Horwell, 
2007). Usually, the ash will have had hours to days to react with the oxygen and water vapor of 
the atmosphere to passivate surfaces before being inhaled by humans. 
Shortly after Mount St. Helens erupted in 1980, a number of experts began to investigate 
the effects of volcanic ash on those who had been exposed to the dust (Bernstein et al., 1986). 
The crystalline silica content of this dust ranged from 3% to 7%. The primary acute effects were 
re¬flected in increased emergency room visits for asthma, bronchitis, and eye discomfort (Baxter 
et al., 1981). The ash was noted to exacerbate chronic respiratory conditions. The increase in 
hospital admissions lasted approximately 3 weeks (Nania and Bruya, 1982), and immune 
parameters were affected even 1 year later (Olenchock et al., 1983). The British West Indian 
Montserrat volcano began erupting in 1995, causing an ash fall from pyroclastic flows that 
contained 10% to 24% crystalline silica (Baxter et al., 1999). Recorded incidences of childhood 
wheezing increased as a result of relatively intense exposures to the ash (Forbes et al., 2003). 
There was a positive association between exposure to volcanic ash from the 2002 eruption of 
Mount Etna, (Sicily, Italy) and acute health effects in the Catania residents. Similarly, Icelanders 
exposed to volcanic ash from Eyjafjallajökull had increased prevalence of respiratory symptoms, 
specifi¬cally asthma and chronic bronchitis, com¬pared with a control population in northern 
Iceland (Carlsen et al. 2012). Sustained long-term health effects have not been reported in 
association with exposures to volcanic ash, although there is speculation that the high cristobalite 
content of the Montserrat ash could lead to silicosis many years later (Baxter, 1999).   
Animal studies that focused on the biological effects of chronic inhalation exposure to 
Mount St. Helens volcanic ash or quartz, under controlled laboratory conditions, indicate 
significant dose-response to both materials (Wehner et al., 1986). The quartz that came from the 
volcano was found to be markedly toxic and fibrogenic; by contrast, the volcanic ash was much 
less toxic (Martin et al., 1984; 1986). Similar results were noted in other animal studies (Beck et 
al., 1981; Raub et al., 1985; Wiester et al., 1985), suggesting that quartz is a much more potent 
pulmonary toxicant than volcanic ash (Beck et al., 1981; Martin et al., 1986; Raub et al., 1985). 
However, the presence of volcanic ash in the inhaled air did increase the “histamine sensitivity” 
of the epithelial irritant receptors (Wiester et al., 1985) as well as inhibit the ability of alveolar 
macrophages to protect against infection (Vallyathan et al., 1995). Ash from Eyjafjallajökull 
disrupted pathogen-killing and inflammatory responses of macrophages, increased bacterial 
replication, and decreased bacterial killing by antimicrobial peptides (Monick et al., 2013).   
The toxicity of volcanic ashes has been evaluated in rats that were dosed once by 
intratracheal instillation (Lam et al., 2002a,b; Latch et al., 2008). Ashes that were obtained from 
the San Francisco volcano field in Arizona (lunar dust simulant) and from a Hawaiian volcano 
(Martian dust simulant) were compared to the toxicity of TiO2 and quartz. Lungs of mice that 
have been harvested 90 days after receiving a dose of 1 mg of lunar simulant showed chronic 
inflammation, septal thickening, and some fibrosis. No changes were seen at the low dose of 0.1 
mg/mouse (Lam et al., 2002a,b). The Martian dust simulant elicited a response that was similar 
to that of the lunar simulant, except that there was an inflammatory and fibrotic response even at 
a dose of 0.1 mg/mouse. The response of the mouse lungs to 0.1 mg quartz was comparable to 
the response to the Martian dust simulant. In another study, the effect of these same simulants 
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was assessed on human alveolar macrophages (Latch et al., 2008). The lunar dust simulant was 
comparable in cell viability reduction and apoptosis induction to the TiO2 (negative control). 
Both were less toxic than the quartz positive control. Both simulants showed a dose-dependent 
increase in cytotoxicity. Recently, studies by Cervini-Silva et al. (2014) demonstrated that 
allophane, the main component of respirable dust derived from aged volcanic soils derived from 
ash and larger sized clasts (Horwell et al., 2015) that was collected from New Zealand, Japan, 
and Ecuador, induces lipid peroxidation in cell membranes, and cytotoxicity in murine 
monocyte/macrophage cells. The lipid peroxidation was controlled by, but not restricted to, 
structural or surface-bound Fe3+. The reactivity of Fe3+ soluble species originating from 
surface-bound Fe3+ or small-sized Fe3+ refractory minerals in allophane surpassed that of 
structural Fe3+ located in tetrahedral or octahedral sites of phyllosilicates or bulk iron oxides. 
Thus the study suggests an adverse effect of dust from volcanic solids may be mediated by 
oxidation. 
Ash samples from Monserrat, Eyjafjallajökull, and Grímsvötn displayed little ability to 
lower levels of lung antioxidants, caused little haemolysis and low acute cytotoxicity in human 
alveolar type-1 like epithelial cells (Horwell et al., 2013). However, cellular mediators MCP-1, 
IL-6, and IL-8 showed chronic pro-inflammatory responses to ash samples from all three 
volcanos, despite substantial differences in the sample mineralogy and eruptive styles (Horwell 
et al., 2013). Cell-free tests showed substantial hydroxyl radical generation in the presence of 
hydrogen peroxide for Grímsvötn samples, as expected for basaltic, Fe-rich ash (Horwell et al., 
2013). “The value of the pro-inflammatory profiles in differentiating the potential respiratory 
health hazard of volcanic ashes remains uncertain” (Horwell et al., 2013). 
4. Evidence from Animal and Human Exposure to Airborne Desert Sand   
The Chinese desert margins experience high atmospheric dust levels, and 
pneumoconiosis is thought to affect several million people in these regions (Derbyshire 2001). 
Nonindustrial silicosis or desert lung syndrome has been recognized in North Africa, the Middle 
East, China, and India (Morman and Plumlee, 2013). Episodic exacerbation of allergenic 
respiratory inflammation by sand dust that originates in Asia or Arizona has been observed in 
East China, the Korean Peninsula, Japan and the United States (Ichinose et al., 2008). Mallone et 
al. (2011) reported finding increases in mortality for cardiovascular, circulatory and respiratory 
causes in Rome related to increases in Saharan dust even when the data were adjusted for ozone 
and temperature. A study in the Canary Islands demonstrated an association with heart and 
respiratory mortality and both indicators of PM in the inhalable size range (PM10), which is the 
fraction of airborne material which enters the nose and mouth during breathing, and respirable 
fraction (PM2.5), which is the fraction that can reach the alveoli, and found rates of respiratory 
mortality increased 4.9% for each increase of 10 µg/m3 in PM10 (Lopez-Villarrubia et al., 
2010). Morman and Plumlee (2013) recently reviewed epidemiological studies that have 
identified associations between far-traveled inorganic mineral dusts from primary sources and 
increased morbidity and mortality in Europe and Asia. Interestingly, effects of PM2.5–10 were 
stronger than those of PM2.5 on cardiac and circulatory mortality during Saharan dust episodes 
(Mallone et al., 2011; Tobias et al., 2011). 
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Direct exposures of "Imprinting Control Region" (ICR; [expression of a gene occurs only 
from one of the two alleles]) mice to sand dusts from Asia (Tengger Desert in north central 
China) and from Arizona via intratracheal instillation (ITI) have been reported to aggravate 
ovalbumin-associated eosinophilic lung inflammation (Ichinose et al., 2008). The aggravating 
effects of the two dusts differed and were related to the mineral content, mainly SiO2 of the dusts 
(Inchinose et al., 2008). In other studies, in which ICR mice were exposed by ITI to sand dusts 
collected from the Tengger Desert or from the atmosphere in Japan, after they had been hot air 
sterilized to remove adhering biological and chemicals substances, Naota et al., (2010) reported 
finding localized accumulation of dust particles in the bronchioles and the alveoli; acute 
inflammatory changes characterized by infiltration of macrophages and neutrophils; degenerated 
alveolar walls and bronchial epithelial cells, as well as a weakened positive immunolabeling for 
laminin, at 24 hours after a single exposure. Positive immunolabelings for interleukin-6, tumor 
necrosis factor–α, inducible nitric oxide synthase, and superoxide dismutase were observed 
mainly in the inflammatory cells in the lesions. Naota et al., (2010) interpreted the results as 
indicating that sand dust particles caused damage to the lung tissue through a direct physical 
effect, and cytokines and oxidative stress generated in the lesion contributed to acute toxicity. 
When the study was repeated and effects observed at longer intervals after exposure it was found 
that the acute inflammation subsided from one week to one month after installation and at 2 and 
3 months after instillation focal infiltration of lymphocytes and accumulation of epithelioid 
macrophages and formation of some granulomas were observed.  
The principal mineral component of windborne desert dusts Asian and North African dust 
is silica, 61 and 63%, respectively, in the form of feldspar and quartz (<20 – 60% of total mineral 
content) (Derbyshire, 2007; Naota et al., 2010). In addition to mineral content these dusts may 
carry bacteria, fungi, and endotoxins, as well as toxic metals and other toxins derived from both 
natural and anthropogenic sources that adversely affect health (Morman and Plumlee 2013). 
Therefore determination of specific effects of a particular constituent of these dusts would be 
difficult. During the Great American Dust Bowl of the 1930s, excessive and prolonged 
inhalation of dust resulted in inflammation of the alveoli, dust pneumonia, and death. 
Characterization of the dusts found high silica content, on average greater than 72%, but no 
pathogenic organisms (Morman and Plumlee 2013). On the other hand, airborne dust samples 
collected for a year from 15 sites across the Middle East showed that at all sites the WHO 
guidelines for maximum ambient PM exposure were exceeded. All silicate mineral particles 
were thinly coated with a silicon-aluminium-magnesium layer and quartz particles were partly 
rounded, without fractured surfaces, and coated with clay minerals and iron oxides; no asbestos 
fibers were found (Engelbrecht et al., 2009). These findings would suggest the toxicity of the 
collected dusts is low but, as noted earlier, the incidence of desert lung syndrome in the Middle 
East is a health concern.  
5. Evidence from Laboratory Animals Exposed to Authentic Lunar Dust 
a. Dermal Effects of Exposure to Lunar Dust 
Crew members can be directly exposed to celestial dust in several ways. After crew 
members perform extravehicular activities (EVAs), they may, as Apollo astronauts did, introduce 
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into the habitat dust that will have collected on spacesuits and boots. Cleaning of the suits 
between EVAs and changing of the Environmental Control Life Support System (ECLSS) filters 
are other operations that could result in direct exposure to celestial dusts. In addition, if the 
spacesuits used in exploration missions abrade the skin, as current EVA suits have, then contact 
with these wounds would provide a source of exposure. Further, if celestial dusts gain access to 
the suits’ interiors, as was the case during the Apollo missions, the dust could serve as an 
additional source of abrasions or enhance suit-induced injuries. Severe abrasion could 
compromise the protective barrier provided by the skin and thereby increase the risk of infection 
and the risk of fluid loss. The abrasive effect of lunar dust on skin has been evaluated with a 
transdermal-impedance technique that measured changes in resistivity of pig-skin, a high fidelity 
surrogate for human skin, after abrasion with lunar soil simulant (JSC-1A), as well as with 
authentic lunar dust (Jones et al., 2009). The transdermal-impedance technique measures damage 
to the stratum corneum, the dry, outermost layer, which is important for the barrier function of 
the skin. The results of these studies show that JSC-1A is abrasive as commercial sandpaper and 
that authentic lunar dust is similarly abrasive. Classical skin toxicology studies, including 
chemical irritancy evaluation and sensitization tests remain to be performed (Jones et al., 2009).  
b. Ocular Effects of Exposure to Lunar Dust 
In accord with recommendations of the Organization for Economic Cooperation 
Development, the Lunar Dust Toxicity Research Portfolio (LDTRP) group utilized a two-step 
approach to assess ocular toxicity of lunar dust. In the first step a 100 mg sample of the 
respirable-sized, jet-milled dust, which had been maintained in dry nitrogen until use, or negative 
or positive control dusts, were applied to the surface of cultured human keratinocytes and 
viability was assessed at 3, 30, and 60 minutes after application of the dust (EpiOcularTM Test). 
As judged by the number of viable cells remaining at each sampling time after exposure, only 
minimal irritancy was demonstrated by this assay for lunar dust (Meyers et al., 2012).  
Because only a minimal irritancy for the dust was demonstrated by the EpiOcularTM 
Test, lunar dust was not expected to be exceptionally irritating if applied in a study in vivo, and 
therefore testing was performed, in rabbits, to assess acute irritation in the intact eye (Meyers et 
al., 2012). In this study 70 mg of non-respirable dust particles (mass mean diameter of 51 µm) 
were applied to the right eyes and the left eyes served as control. Only slight redness and 
swelling of the conjunctiva was observed at the first (1-hour) observation time and no adverse 
effects were noted in the cornea, iris, or conjunctiva at any of the subsequent observation times 
(24, 48, and 72 hours) (Meyers et al. 2012). The maximum average irritation rating observed at 
1-hour corresponded to the Draize scale rating of minimally irritating (Meyers et al. 2012). 
In addition to the mechanical irritation, it is possible that the cornea could be adversely 
effected by molecular changes induced by chronic exposure to low levels of dust that possess 
surface features that could facilitate oxidative damage. Therefore, to assess this possibility, 
Theriot et al. (2014), isolated ribonucleic acid (RNA) from corneas of rats that were collected at 
1 day and 7 days after exposure expose to filtered air (controls) or 20, or 60 mg/m3 jet mill 
prepared respirable sized lunar dust for a total of 120 hours (Lam et al., 2103). Microarray 
analysis performed using the Affymetrix system identified dose-dependent increases in gene 
14	  
	  
expression in dust-exposed animals in pathways related to oxidative stress response, 
mitochondrial dysfunction, fibrosis, epithelial healing, TGF-­‐ß signaling, and extracellular matrix 
remodeling (Theriot et al., 2014). Genes affecting processes related to cell migration, cellular 
proliferation, and eye development were also found to be altered by exposure to lunar dust. The 
findings suggest that exposure to lunar dust for 120 hours at a concentration as low as 20 mg/m3 
is sufficient to elicit a molecular response in the cornea. As noted by these investigators, 
“additional studies are required to fully assess the risk of vision impairment and the mechanistic 
responses initiated in cornea exposed to lunar dust as well as the potential for long-­‐term effects 
to astronaut health”. 
c. Pulmonary Effects of Exposure to Lunar Dust 
Early efforts to assess the toxicity of lunar dust produced little useful information. In one 
study interpretation was complicated by spontaneous pathology in control animals (Holland & 
Simmonds, 1973). Other studies (Batsura et al., 1981; Kustov et al., 1974, 1989) were also 
inadequate and the range of findings extended from no effects (Kustov et al., 1974) to fibrosis 
(Kustov et al., 1989). Therefore, when new missions to the moon were being planned in the last 
decade the toxicity of lunar dust remained to be determined. This deficiency imposed a critical 
challenge to those responsible for designing ECLSS of the vehicles and habitats that would be 
used in the lunar exploration missions. This deficiency was addressed by the NASA Office of the 
Chief Health and Medical Officer who requested “…recommendations for defining risk criteria 
for human lunar dust exposure and a plan for the subsequent development of a lunar dust 
permissible exposure limit.”  The multi-center Lunar Airborne Dust Toxicology Assessment 
Group (LADTAG) was formed to respond to this request. The LADTAG was comprised of 
technical experts in lunar geology, inhalation toxicology, biomedicine, cellular chemistry, and 
biology from within the agency as well as other leading U.S. experts in these fields from other 
federal agencies, academia, and industry. In an initial LADTAG workshop that was held in 2005, 
the experts noted that they were unable to reconcile individual expert opinions to set an 
inhalation standard based on existing data. The array of opinions from these experts spanned a 
300-fold range (i.e., 0.01 to 3 mg/m3). The members of the LADTAG concluded that research 
was necessary to narrow this wide uncertainty range, the lower end of which could not be met by 
known methods of environmental control, and that there was an urgency to determine the 
standard so that environmental systems for the then-planned lunar vehicles and habitats could be 
appropriately designed. Therefore, gaps in knowledge needed to determine the characteristics of 
lunar dust that contribute to its toxicity, to determine the toxicity of lunar dust to the respiratory 
system, to the skin and to the eyes, and to establish a permissible exposure limit for airborne 
lunar dust, were formally documented by the Human Research Program (HRP). Studies to 
address these gaps were solicited and funded, and a multidisciplinary LDTRP group, consisting 
of teams of toxicologists, geologists, and chemists, was engaged to conduct studies needed to 
address the gaps.   
It was anticipated that exposures of lunar exploration crews to dust would occur during 
an interval lasting no more than six hours, which would begin when dust was introduced into a 
habitat by crewmembers returning from surface activities and end when high efficiency 
particulate air (HEPA) filters re-established low, baseline, levels of dust. The work schedule of 
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crews was expected to follow a typical work week with 5 days that included surface activity and 
2 days of rest which required no activity outside the habitat, and therefore no introduction of dust 
into the habitats on those days. Therefore studies were designed to obtain data that would support 
a recommendation for an exposure limit based upon a time weighted average exposure, as is the 
basis for an Occupational Safety and Health Administration PEL, and account for episodic 
exposures to airborne lunar dust for missions involving no more than six months duration. 
The sample of authentic lunar dust used to assess toxicity was acquired from the Curation 
and Analysis Planning Team for Extraterrestrial Materials at the Johnson Space Center (JSC). 
The sample obtained, 14003,96, had been collected by the Apollo 14 crew. Although in the lunar 
highlands, the soil at the landing site was comprised of mineral constituents from both major 
geological regions (Meyer et al., 2011), the highlands and mares regions. Respirable size 
(PM2.5) lunar dust aliquots for use in toxicological assessments were obtained from the parent 
14003,96 sample in several ways by the Geology Team. These are described in detail by McKay 
et al. (2015). A cyclonic separation method, which utilizes an air vortex and gravity to separate 
particulates was utilized to separate a few grams of native respirable-size dust from the parent 
sample. Because of damage to seals of containers caused by the dust when it was collected, it 
was expected that the surface reactivity of the native dust would have been passivated by 
exposure to atmosphere during the many years the archived samples were stored (Gaier, 2007). 
To address this concern, other methods involved grinding a cyclonic-separated fraction by ball 
mill or jet mill and then separating the respirable sized particles from the ground dusts with the 
cyclone system, were employed. Grindings and separations were conducted in a dry nitrogen 
environment to minimize any loss of surface reactivity generated in the dusts by grinding. 
Grinding was expected to generate silicon- or oxygen-based radicals (“dangling bonds”) and 
expose reduced iron, both of which can react with water to produce ROS (Wallace et al., 2009). 
Grinding therefore served as a surrogate for processes that activate lunar dust in situ. The 
volumetric mean diameters of the respirable-size dusts were 1.8, 2.1, and 2.5 µm for the ball-
milled, native, and jet-milled dusts, respectively. Fe0 is present in lunar dust particles and the 
fraction of total iron present as Fe0 increases as the particle size diminishes, at least to 2 µm 
(Taylor et al 2011). Therefore respirable dust produced by grinding of larger particles contained 
lower amounts of Fe0 than the native respirable-sized lunar dust. Otherwise, the mineral 
compositions of the three lunar dusts preparations were similar. (McKay et al., 2015).  
Assessment of pulmonary toxicity of lunar dust by LDTRP was accomplished in two 
phases that utilized different methods of exposure and several systems of analysis. Both phases 
utilized rats (Fisher 334) for exposure assessment. Rats were chosen because they are more 
responsive to inhaled particles than other rodents (Bermudez et al., 2004; Maudley, 1997); the rat 
and human lung responses to inhaled particles are, qualitatively, quite similar (Castranova, 
2000); carcinogenesis and risk of tumor from exposure to quartz are similar in man and rats 
(Kuempel, 2009; Roller, 2009). In the first phase, animals were exposed by ITI to three 
respirable-sized lunar dusts (one native, and two that had been produced by grinding) and two 
standard dusts of well-established and widely different toxicities, quartz (PEL = 0.1 mg/m3) and 
TiO2 (PEL = 5.0 mg/m3) at dosages of 0, 1, 2.5 or 7.5 mg/rat. Cellular and biochemical markers 
of toxicity were assayed in bronchoalveolar lavage fluid (BALF) collected from lungs at 1 and 4 
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weeks after instillation (James et al., 2013). Comparative benchmark dose analysis was utilized 
in which the effects of the various dusts on responsive markers of toxicity were scaled to those of 
the dusts of know toxicity. The basis of comparison among sensitive biomarkers was the amount 
of dust predicted from the dose-response curves generated by the Benchmark Dose software (US 
EPA) that would be required to effect a change equivalent to 1 standard deviation from the 
control mean. On this basis, the derived PELs for the lunar dust preparations were 1.3 ± 0.4 
mg/m3 (jet-milled dust), 1.0 ± 0.5 mg/m3 (ball-milled dust) and 0.9 ± 0.3 mg/m3 (unground, 
natural dust). This approach indicated that the toxicities of the three preparations of lunar dust 
were of indistinguishable toxicity and that lunar dust is more toxic than the nuisance dust TiO2 
but less toxic than quartz. The lowest PELs among the various endpoints modeled were 0.5 
mg/m3 and the average was approximately 1 mg/m3. Therefore, James et al (2013) concluded 
that a PEL in the range of 0.5 to 1 mg/m3 “was reasonable for the episodic exposures expected 
inside a lunar habitat during a prolonged mission on the lunar surface”. 
ITI studies have the benefit that they require far less material than inhalation studies, a 
very important consideration when the material to be studied is in very limited supply and 
extremely precious, as is the case with lunar dust, and in this regard is a valuable tool with which 
to determine the approximate dose range that may be appropriate for later inhalation studies 
(Driscoll, 2000). As a result, the ITI study was used to facilitate choices of doses for use in an 
inhalation study, the lower of which was expected to result in a no-observable-adverse-effect 
level (NOAEL). However, there are a number of widely held concerns with ITI as a means of 
assessing pulmonary toxicants. The toxicant is introduced to the target organ (lung) in a dose or 
at a dose rate that substantially exceeds that which would have occurred during inhalation. The 
toxicant is introduced via an invasive mechanism that may result in a distribution of the instilled 
material within the respiratory tract that will likely differ from that resulting from inhalation. The 
vehicle within which the toxicant is suspended or dissolved could influence the distribution, 
affect the lung directly, or modify the effect of the instilled toxicant. Finally, the anesthetic 
utilized during the installation could alter the initial effects of the inhaled material (Driscoll, 
2000).  
Cognizant of the merits and limitation of ITI, the LDTRP conducted a second phase of 
toxicity in animal studies that involved exposures by nose-only inhalation and where the 
selection of the dose of the initial exposures was informed by the results of the ITI study (Lam et 
al., 2013). In phase 2, rats were exposed by nose-only inhalation, for six hours per day, five days 
per week for four weeks to jet mill ground respirable size lunar dust. Jet milled dust was utilized 
because ITI studies had demonstrated no significant differences among the toxicities of the lunar 
dusts preparation and this preparation was available in quantities required for the study. BALF, 
lungs and lymph nodes (left tracheobronchial and parathymic) were collected at 1 day, 1 week, 4 
weeks and 13 weeks post-exposure. Two inhalation sessions were performed. Based on the 
results of the ITI experiments, animals were exposed to room air or to 21 or 61 mg/m3 respirable 
sized lunar dust. Slight effects were observed in lungs of rats exposed to 21 mg/m3 and mild to 
moderate pulmonary toxicity was evident in the group exposed to 61 mg/m3. Because mild 
effects were observed in the lower-dose group, a NOAEL was not available from this study, and 
a second inhalation study was conducted, 1 year after the first, which targeted exposure doses of 
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2 and 7 mg/m3 (Lam et al, 2013).  BALF showed concentration-dependent changes in total cell 
and neutrophil counts (evidence of inflammation), total protein concentrations (a sign of tissue 
damage), and several cellular enzymes (indicators of cell death) in animals exposed to the two 
higher concentrations but no significant difference were found in biomarkers measured in BALF 
of control animals and those exposed to the two lower concentrations of lunar dust. Likewise, 
inflammation, septal thickening, fibrosis and granulomas were observed in the lungs of animals 
exposed at the two higher concentrations, but no lesions were detected in rats exposed to the 
lower doses. Therefore, 6.8 mg/m3 was the highest NOAEL observed in rats after four weeks of 
intermittent exposure (Lam et al., 2013). Applying an uncertainty factor of 3 for extrapolation 
from rats to humans and a factor of 6 for extrapolating from 1 to 6 month exposure provided an 
estimated PEL of 0.4 mg/m3 (Lam et al., 2013). 
Although it is a well-recognized method for establishing toxicity factors, a NOAEL has 
several known limitations. These include the fact that it is highly dependent upon the design of 
the study. It is influenced by the concentration intervals, the endpoints examined, and limited to 
the doses actually tested. An alternative to the traditional NOAEL approach is the application of 
benchmark dose (BMD) analysis (Crump, 1984). The availability of the BMD analysis provided 
an opportunity to (1) compare and contrast the level of toxicity of lunar dust assessed with this 
method to that assessed using a NOAEL as a point of departure, and (2) contrast the assessment 
of toxicity obtained from the inhalation studies with assessments obtained by BMD analysis of 
dose responses to lunar dust in the ITI study. When BMD was applied to responsive biomarkers 
and BMDs were extrapolated to humans, using a species factor of 3 and extrapolated from a 1-
month exposure to an anticipated 6-month lunar surface exposure (Scully et al., 2013), PELs 
were 0.6 and 0.9 mg/m3, when less or more restrictive data sets were used, respectively. The less 
restrictive data set included non-normally distributed data that were successfully modeled. This 
range was very similar to PEL range (0.5–1.0 mg/m3) derived from the ITI study (James et al., 
2013) and to the PEL (0.4 mg/m3) determined from a NOAEL from the same inhalation studies 
(Lam et al., 2013). 
Taken together the results of the ITI and inhalation studies led the JSC Toxicology Group 
to recommend 0.5 mg/m3 as a safe concentration for periodic exposures during a 6-month 
mission on the lunar surface. The Group noted that their recommendation was likely to be 
conservative but it should not be applied to dust from regions of the moon, such as the poles or 
the dark side, until those dusts are studied to determine their similarity to mare and highland 
dusts. The results and recommended PEL were presented to the Office of Chief Health and 
Medical Officer’s (OCHMO) staff and to an external Review Committee organized through 
NASA's Research and Education Support Services in December 2013. The Review Committee 
produced a report and recommendations in late January 2014. The original recommendation was 
revised based on input from the Review Committee, and a final 6-month episodic exposure limit 
for airborne lunar dust of 0.3 mg/m3 was presented to the Medical Policy Board in April 2014 
and accepted for incorporation into NASA Standard 3001 (NASA Human Research Roadmap, 
2015). 
6. Evidence of Potential Risks to Other Organ Systems  
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The harmful effects to tissues directly exposed to lunar dust (lung, cornea, skin) have 
been examined, as described above, but an extensive and growing body of literature (for 
examples, see the epidemiological studies in the sections on effects of exposure to particulate 
components of urban air pollution (Section B2) and to airborne desert sands (Section B4)) raises 
substantial concern that exposure to celestial dust could have harmful effects on other directly, or 
indirectly, exposed tissues. The risk of adverse effects caused by inhalation of celestial dusts to 
the nose, pharynx, trachea, and larger air conducting areas of the respiratory system and irritation 
or damage to the mucosa of the gastrointestinal system by ingested dust remains to be assessed. 
The risk of adverse effects of celestial dusts on systems such as the cardiovascular, nervous 
systems and immune systems that may be secondarily, or indirectly affected by inhaled or 
ingested dusts also remains to be characterized. 
The residence time of particles depositing in the upper respiratory system, nose, pharynx, 
trachea, and larger air conducting areas are typically very short due to mechanical clearance 
provided by nose blowing, sneezing, or the mucociliary escalator (Lippmann et al., 1980). Most 
particles are removed from the tracheobronchial region within 24 hours. However ultrafine 
particles may submerge into the mucus of the airway fluid, which may result in their prolonged 
retention in this region (Schürch et al., 1990; Stahlhofen et al. 1995). Local deposition is 
important and build-up of concentration on some surfaces can be sufficiently high that the 
capacity for clearance can be exceeded. Local retentions could account for nasal cancers in 
furniture workers and for laryngeal cancers in cigarette smokers (Lippmann et al., 1980). Dietz et 
al. (2004) demonstrated that occupational exposures to cement dust is a risk factor for laryngeal 
carcinoma. Cement dust contains a mixture of heavy metals that are known human carcinogens 
(Ogunbileje et al., 2013). These findings are concerning given that Martian dusts contain 
substantial amounts of heavy metals (Schuerger et al., 2012). The finding of a weak association 
between silica or silicosis and laryngeal cancer (Chen et al., 2012) also raises concern of possible 
adverse effects of inhaled celestial dusts in the upper portions of the respiratory system.  
Particles cleared from the respiratory tract move to the oropharynx and are then 
swallowed and thereby transferred from the respiratory system to the gastrointestinal (GI) system 
(Kreyling and Scheuch, 2000; Lippmann et al., 1980). Thus, ingestion, indirectly by transfer 
from the respiratory system, or directly, provides another potential route of exposure to celestial 
dusts. Therefore, potential risk of adverse effects of ingested dust upon the GI system must be 
considered. A “borderline” association between exposure to dust and the diffuse form of stomach 
cancer has been found for miners and quarry workers (Santibañez et al., 2012). Lin et al. (2014) 
recently reported evidence for the association between exposure to chrysotile (white asbestos) 
mining dust and excess mortality from cancers of the stomach, esophagus, and liver among 
workers with high cumulative exposure to this mineral dust. García-Pérez, et al. (2015) found 
excess cancer mortality (colorectal cancer) in the vicinity of Spanish facilities that produce 
cement. A meta-analysis of studies of occupational exposure to asbestos found that exposure is 
associated with a moderate increased risk of stomach cancer (Fortunato and Rushton, 2015). The 
durations of occupational exposures in the studies related above far exceed the acute exposures 
that are likely to be experienced by crews exploring celestial bodies, but these finding will take 
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on greater significance and relevance when extended habitation on celestial bodies increases the 
extent of exposures. 
In addition to the consequences to tissues directly exposed to a toxicant, other tissues 
may be secondarily affected by translocation of the toxicant from the site of initial contact, or by 
adverse effects propagated to remote tissues by reactions produced in tissue in contact with the 
toxicant. The American Heart Association (AHA) in 2004 released its first scientific statement 
on “Air Pollution and Cardiovascular Disease” and concluded that exposure to PM air pollution 
contributes to cardiovascular morbidity and mortality. Pope and Dockery (2006) reviewed the 
literature published between 1997 and 2006 and concluded there is “persuasive evidence that 
exposure to fine particulate air pollution has adverse effects on cardiopulmonary health”. In a 
subsequent statement on this topic the AHA, as noted by Brook et al. (2010), identified several 
new conclusions: 
“Exposure to PM 2.5 µm in diameter (PM2.5) over a few hours to weeks can trigger 
cardiovascular disease–related mortality and nonfatal events; longer-term exposure 
(e.g., a few years) increases the risk for cardiovascular mortality to an even greater 
extent than exposures over a few days and reduces life expectancy within more highly 
exposed segments of the population by several months to a few years; reductions in PM 
levels are associated with decreases in cardiovascular mortality within a time frame as 
short as a few years” 
According to the World Health Association approximately 3.7 million premature deaths 
worldwide in 2012 were attributable to urban outdoor air pollution and PM affects more people 
than any other pollutant (WHO, 2014). Increased acute mortality that is associated with particle 
“events” is attributed to CV disease (NRC, 2004). PM in air pollution has been shown to impair 
vascular function, increase blood pressure, promote thrombosis and impair fibrinolysis, 
accelerate the development of atherosclerosis, increase the extent of myocardial ischemia, 
decrease heart rate variability, and increase susceptibility to myocardial infarction (Miller et al., 
2012; Mills et al., 2007, 2009; Scapellato and Lotti, 2007). The most severe of these effects are 
found among susceptible populations with preexisting cardiovascular diseases, diabetes, obesity, 
hypertension or advanced age (Bhatnagar, 2006), but PM could also promote systemic 
inflammation in young, healthy individuals (Allen et al., 2011; Rich et al., 2012; Riediker et al., 
2004; Schaumann et al. 2004; Wu et al., 2012). The association of airborne PM with 
cardiovascular disease is also evident from observation that in cases of sudden and marked 
reductions in air pollution (e.g., sudden changes in policy or strikes leading to cessation of 
emissions), there have been clear reductions in hospital admissions for cardiopulmonary diseases 
and deaths (Maynard, 2015) and acute reductions in biomarkers of pulmonary and systemic 
inflammation, oxidative stress, and hemostasis and improvements in measures of cardiovascular 
physiology in healthy, young adults (Zhang et al., 2013).  
In the case of “overloading”, where the amount of dust entering the lung exceeds the 
capacity of the lung to clear (eliminate) the inhaled dust, the movement of inhaled particles from 
lungs to the lymph nodes has been observed (Dodson et al, 2007; Oberdorster et al., 1988). 
20	  
	  
Particles that gain access to the post-nodal lymph have the potential to reach any organ of the 
body (Dodson et al., 2007). Ultrafine particles (UFP) or nanoparticles (NP) with a largest 
dimension less than 0.1 µm, can transit from the lungs and reach other organs via the lymphatics, 
by the blood circulatory system (Choi et al., 2010; Geiser and Kreyling, 2010; Nel et al., 2006; 
Oberdorster et al., 2004), or enter sensory nerve endings embedded in airway epithelia and from 
there be translocated to structures of the central nervous system (CNS) (Elder et al., 2006; 
Oberdorster et al., 2005; Sarkozi et al., 2009; Wang et al., 2008). Nakane (2012) performed a 
systematic review of the literature on translocation of inhaled particles and used categorical 
regression to relate route of exposure, particle size, particle material, and animal species to the 
site of particle translocation. His analysis demonstrated “effects for particle size and particle 
material were large, while the effects for animal species and exposure route were relatively 
small” (Nakane, 2012). A broad relationship between particle size and site of translocation was 
demonstrated: <10 µm for translocation in lung tissue, <1 µm for translocation to the blood, and 
< 50 nm for translocation to the brain and remote organs (Nakane 2012). NP composed of heavy 
metals and salts, metal oxides, inorganic carbons, and plastics have been observed to translocate 
from the respiratory system to adjacent lymph nodes and organs beyond the lungs. When NP 
were found in the brain this was almost invariably subsequent to exposure by inhalation or 
intranasal administration (detected in 8 of 10 studies) and only once (1 of 6 studies) following 
intratracheal instillation. The later observation, is consistent with the mechanisms observed by 
others (Elder et al., 2006; Oberdorster et al., 2005; Sarkozi et al., 2009: Wang et al., 2008) that 
NP deposited in the nasal mucosa are taken up the axons of the olfactory bulb and transported to 
the brain.  
Studies conducted with NP composed of polystyrene or diesel exhaust particles (DEP) 
injected into the blood of hamsters demonstrate that translocation of NP from the lungs to the 
blood may increase vascular inflammation, clotting, and the risk of myocardial infarct (Nemmar, 
2004). Studies with cultured endothelial cells demonstrated that iron translocated to blood 
vessels could damage endothelium by increasing its permeability through the production of ROS 
and remodeling of microtubules (Apopa et al., 2009). DEP-produced ROS caused oxidative 
stress, which reduced the bioavailability of endothelium-derived nitric oxide, and thereby 
antagonized acetylcholine-mediated relaxation in exposed preparations of rat aorta (Miller et al., 
2009). A number of in vitro studies with a variety of cell types demonstrate that metallic 
nanoparticles (gold, magnetite) cause dose-dependent disruption of cytoskeleton and defects in 
the lysosome function that, together, can promote autophagy (Cohignac et al., 2014). Because of 
the epidemiological association of air pollution with increased morbidity and mortality, and the 
very rapid rise in use of nanomaterials in the nascent nanotechnology industry, studies of the 
toxicity of UFP or NP have been conducted with particles of anthropogenic origin, such as 
combustion-derived NPs (CDNPs), which are carbon centered and derived principally from 
traffic (Donaldson et al, 2013) and with engineered nanoparticles, such as gold, silver, TiO2, 
iridium, polystyrene, etc. (Simko et al., 2010). The translocation of these nanoparticles is low; no 
more than 5% of the particles move from the lungs to remote organs (Donaldson et al., 2013; 
Simko et al., 2010). The significance of this small translocation fraction to progression of disease 
at remote sites has been questioned (Donaldson and Poland, 2013). If NP mass is the effective 
determinant of toxicity in the organs to which they translocate, then it would seem unlikely that 
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sufficient mass would be accumulated remotely to be effective. However, if NP number and 
reactive surface area are the principle determinants of toxicity, then chronic exposure to NP may 
be hazardous (Geiser and Kreyling, 2010; Kreyling et al., 2006; Tran 2000). CDNPs, which 
include coal fly ash, diesel exhaust particles, welding fumes, and carbon black, contain large 
surface areas on which catalytic chemistry produce free radicals that promote oxidative stress 
and inflammation (Donaldson et al., 2005). Nanoparticles, because they contain substantially 
more surface area than the same mass of fine particles, have a greater capacity than fine particles 
to induce inflammation and are generally more toxic than larger particles of the same chemistry 
(Bermudez et al., 2004).   
The possibility that ingested dust particles, as with inhaled particles, may be translocated 
from the site of initial deposition to remote organs has been investigated. While most studies, 
using TiO2, have found no, or negligible, translocation of nanoscale or pigment grade TiO2 from 
the gut to the systemic circulation (Warheit and Donner, 2015), a few studies have observed 
movement of particles from the gut to other organs. After administering nanoparticles of TiO2 (5 
mg/kg) by gavage to adult mice Wang et al. (2007) found, two weeks after administration, that 
particles had translocated from the gut and were principally deposited in the liver, spleen, lungs, 
and kidneys. Inflammation and hepatic necrosis, and nephrotoxicity were observed but no 
abnormal changes were seen in the heart, lung, testicle, ovary, and spleen. Tassanari et al. (2014) 
reported histopathological effects in the thyroid, adrenals, ovaries, uterus, testes, and spleen in 
mice after oral administration of 1-2 mg/kg body weight for 5 days. On the other hand, 
MacNicoll et al. (2015) found that “5 mg/kg body weight of TiO2 nano- or larger particles did 
not lead to any significant translocation of TiO2 (measured as titanium) either to blood, urine or 
to various organs in rat at any of the time intervals studied over a 96 h post-administration 
period”. Jones et al. (2015) found that “very little titanium dioxide is absorbed gastrointestinally 
at 4 days after an oral challenge”. The issue of translocation of ingested nanoparticles remains 
unsettled. 
The relevance of the finding of potential adverse effects caused by anthropogenic 
nanoparticles translocated from the respiratory system to remote organs to risk of adverse health 
effects from exposure to celestial dusts depends upon the composition and abundance of 
nanoparticles present in the celestial dusts. On small asteroids where gravity is insufficient to 
retain small particle formed by comminution resulting from micro meteor impacts, UF particles 
may be few. On the moon 2% of the soil is comprised on respirable size lunar dust and a size-
distribution study of an Apollo 14 sample showed that the most frequent particle size was in the 
0.1 to 0.2 µm range and “there is a smooth decrease in particle size down to 10s of nanometers” 
(McKay et al., 2015). The presence of nanoparticles and the abundance of highly reactive 
nanophase iron spheres in lunar dust suggests that risks to other organs from translocation of 
inhaled dust cannot be completely discounted. The risk posed by translocation of Martian dusts 
is not assessable because the size distribution of dusts in the UF, NP range at the Martian surface 
is unknown. 
The risk to other organs posed by inhaled toxicants does not require that the particles 
leave the respiratory system in order to exert adverse effect in other systems. Pulmonary derived 
mediators (Seaton, 1995) or activation of sensory nerve fibers (C fibers) in response to ingested 
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toxicants could produce effects at sites beyond the lungs. Seaton et al. (1995) proposed that 
deposition of particles in the lung provokes a low-grade alveolar inflammation with a secondary 
systemic inflammatory response emanating from “spill over” release of cytokines and other 
mediators from the lungs resulting in adverse cardiovascular effects in susceptible individuals. 
Many finding have been consistent with this hypothesis. Exposure to PM10 was associated with 
changes in plasma viscosity (Peters et al., 1997), elevated levels of fibrinogen (Ulrich et al., 
2002; Gilmour et al., 2005), platelet activation (Nemmar et al., 2003), bone marrow stimulation 
and an increase in circulating neutrophils (PMN) and monocytes (Bai et al., 2013; Brook 2010), 
and PMN adhesion with myeloperoxidase deposition and local oxidative stress in systemic 
venules (Nurkiewicz et al., 2006). While there is ample evidence to demonstrate that PM causes 
inflammation that could spread from the lung to the circulation there is some uncertainty as to 
how closely pulmonary and systemic inflammation are related and under what conditions and to 
what extent systemic inflammation contributes to acute or chronic clinical events observed in 
compromised or healthy individuals exposed to high levels of PM (Bhatnagar et al., 2006). 
While large panel studies show increased plasma fibrinogen and C-reactive protein levels and 
viscosity that correlated with PM exposures, controlled exposure studies have failed to 
demonstrate concurrent changes of pro-inflammatory mediators in lung and blood (Scapellato et 
al., 2007). The converse has also been observed – proinflammatory systemic effects occur in the 
absence of significant pulmonary inflammation (Araujo and Nel, 2009). In the latter case, it is 
possible that “activation of inflammatory molecular pathways could have occurred without 
histological evidence of overt pulmonary inflammation” (Araujo, 2011). Variations in the 
strength and the consistency of the association between PM exposure and systemic inflammation 
likely reflects differences in PM chemistry, duration and intensity of exposures, and differences 
in susceptibility of subject populations (Brook et al., 2010). The potential for systemic 
inflammation in response to inhaled celestial dusts could be expected to be affected by the same 
variables, except that spaceflight crews are uniformly more robustly healthy than the general 
population.  
Studies of silicosis with animals have regularly found that silica induces pulmonary 
inflammation (Castranova, 2004). These studies have typically utilized instillation or inhalation 
exposures that model acute silicosis (Langley et al., 2011). Therefore, extrapolations from 
findings of studies of human response to airborne PM, and from the vast majority of studies of 
silicosis conducted with animals, may inform expectations of the consequences of acute 
exposures of celestial dust that are sufficient to produce pulmonary inflammation. However, in 
humans, acute silicosis is exceedingly rare and chronic silicosis, which manifests after long term 
exposure to occupational doses, is the greater hazard (Chong et al. 2006). In studies in which rats 
were exposed by inhalation to occupationally relevant doses of silica granulomas developed 
many months after silica inhalation was ended, as in humans (Greenberg et al., 2007), and the 
granulomas resembled human silicotic granulomas in their structure and histopathology (Langley 
et al., 2011). However, the granuloma formation was not associated with significant 
inflammation, cell death or lung injury in early stages but only at late stages (Langley et al. 2004; 
2010). In a toxigenomic study of rats exposed to occupationally relevant doses of silica the 
prototypic proinflammatory cytokines TNFα, IL1β, IL6, and IFNγ did not appear to be 
significantly involved in the granuloma formation (Langley et al., 2011). These finding are 
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consistent with those of others who reported that proinflammatory cytokines may not be 
necessary for fibrosis (Giordano et al. 2010; Lo Re et al. 2010). The finding that silicotic 
granulomas in humans cannot be prevented with corticosteroids further raises uncertainly about 
the association of inflammation with that silica-induced endpoint. Therefore, in occupationally 
relevant exposures to toxic silicates, processes other than inflammation likely contribute more 
substantially to the biologically significant endpoints. Such processes may be relevant to chronic 
low levels of exposures to celestial dusts during prolonged periods of habitation on surfaces of 
celestial bodies. 
Oxidative stress is associated with the development of both acute and chronic silicosis 
(Castranova 2004; Cox et al., 2011; Shi et al. 1998), and oxidative burden has been shown to 
progressively rise even after exposures to silica were ended and the lungs had cleared most of the 
silica (Fubini and Hubbard 2003; Rimal et al. 2005). Systemic oxidative stress could be induced 
by inspired PM if organic chemicals and transition metals are released from the lung to the 
systemic circulation, or cause release of ROS from the lung secondary to pulmonary 
inflammation (Araujo et al., 2008; Mills et al., 2007). PM has also been shown to lead to 
enhanced lipid peroxidation in the lungs resulting in increased levels in the BALF of oxidized 
phospholipids (Kampfrath et al., 2011). PM can increase lipid peroxidation in the plasma, 
resulting in low density lipoprotein particles that are either more oxidized or more susceptible to 
oxidation, and high density lipoproteins with dysfunctional anti-oxidant and anti-inflammatory 
properties (Yin et al., 2013). These effects may occur in parallel with or function as pro-
atherosclerotic effects (Araujo and Rosenfeld, 2015). Because oxidative stress and inflammatory 
processes are linked, investigating the effect of PM on oxidative stress, per se, in humans, is 
difficult. Only a few studies have directly investigated the occurrence of systemic oxidative 
stress in humans in response to exposure to ambient PM (Brook et al., 2010). Studies of young 
adults conducted in Denmark demonstrated elevations in biomarkers of protein, lipid, or DNA 
oxidation in relation to PM exposure from traffic sources (Brauner et al., 2007; Sorensen et al., 
2003; Vinzents et al., 2005), and in studies conducted in Taiwan, also performed on young 
adults, increased levels of 8-hydroxy-2-deoxyguanosine adducts in DNA were found after short-
term elevations in ambient PM (Chaung et al., 2007). Increases in plasma homocysteine, a 
circulating mediator of oxidative stress have been seen after exposure to ambient PM (Baccarelli 
et al., 2007; Park et al., 2008). Systemic oxidative response to elevated air pollutants among 
elderly women in Mexico City was moderated by supplementing diet with antioxidant omega-3 
polyunsaturated fatty acids (Romieu et al., 2008). Systemic oxidative stress is a mechanism by 
which inhaled toxic celestial dusts could affect other organs. 
A role of the central nervous system in mediating effects of PM10 on the cardiovascular 
system has been identified in numerous studies (Bai et al., 2007). PM can stimulate vagal 
afferents and enhance the sensitivity and reactivity of neural reflexes that can promote local 
and/or systemic inflammation and the release of inflammatory mediators and increase heart rate 
and reduce heart rate variability (Bai et al., 2007). Reduced heart rate variability is associated 
with increased risk for cardiac events (Ghelfi, 2011; Kleiger et al., 1987; Tsuji et al., 1996). A 
review of the literature that implicates the autonomic nervous system in the mediation of 
cardiovascular effects of PM concluded that “the evidence for this link is relatively consistent for 
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effects upon the heart”, such as decreased heart rate variability but the relevancy to vascular 
effects is less clear (Donaldson et al., 2013). Therefore a potential for inspired celestial dust to 
affect pulmonary afferent nerve fibers, which produce effects at sites beyond the lungs, should be 
included in considerations of the potential toxicity of these dusts. 
In addition to the adverse effects upon respiratory and cardiovascular systems air 
pollution negatively affects the brain and central nervous system (Costa et al., 2014). 
Epidemiological studies and studies with animals have shown that exposure to air pollution may 
lead to oxidative stress and neuroinflammation, damage to the brain parenchyma and 
vasculature, and disruption of the blood–brain barrier, (Block e al., 2012; Calderon-Garciduenas 
et al., 2008; Costa et al., 2014). Effects upon the CNS, could have secondary health consequence 
if altered CNS functions affect modulation of the pulmonary, cardiovascular and immune 
systems (Block et al., 2012; Perez et al., 2015). The observation that the effects of the PM on the 
CNS are attributable to its metallic components (Block and Calderon-Garciduenas, 2009; 
Calderon-Garciduenas et al., 2013) may be relevant to assessing risks posed by inhalation of 
celestial dusts containing heavy or transitions metals. 
7. Evidence from Properties of Dusts Associated with Toxicity and 
Understandings of Mechanisms of Toxicity – Implications for Assessing Potential 
Toxicity of Celestial Dusts. 
Much effort has been expended in attempts to determine the relationships between 
various physiochemical characteristics of mineral dusts and other particulates and their toxicities 
in order to elucidate the mechanism(s) that produce their toxic effects. Unfortunately despite 
much effort, a complete understanding of the mechanism remains elusive. Studies have 
examined size, shape, density, charge, crystallinity, chemical composition, and dissolution rate, 
and each of these properties has been shown to affect toxicity (Braakhuis et al., 2014; Brom et 
al., 2011; Fubini et al., 2007). Physical properties such as size, shape, density, and charge 
determine a particle’s deposition and distribution in the pulmonary system; clearance and 
translocation are affected by their size, shape and surface characteristics and ability to induce 
inflammation and oxidative stress is related to surface characteristics (Braakhuis et al., 2014; 
Brom et al., 2011; Fubini et al., 2007) and these conditions lead to adverse biological endpoints 
that can include histopathology, granulomas, fibrosis, and cancer (Braakhuis et al., 2014; Brook 
et al., 2010; Gray et al., 2015; Zhang et al., 2013) in the pulmonary system as well as vascular 
damage in other systems (Burn and Varner, 2015; Scapellato et al., 2007). The importance of 
surface properties in driving processes important to the toxicity of the particle is demonstrated 
convincingly by the repeated observations that “surface modifying agents, such as 
polyvinylpyridine-N-oxide (PVPNO) and aluminum lactate,  inhibit most adverse reactions to 
silica in vivo and also decrease the generation of ROS and DNA damage caused by silica” 
(Fubini et al., 2007). Masking reactive surfaces would facilitate clearance of particles and 
decrease effects due to activation of macrophage, and PVPNO also scavenges particle-generated 
hydroxyl radicals (Fubini et al., 2007). However, data from inhalation studies conducted with 
lunar dust having different surface reactivity characteristics indicate little to no difference in all 
measures of toxicity (unpublished data).    
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The importance of surface features to particle toxicity is also illustrated by the finding 
that inhalation of freshly ground quartz, when compared to inhalation of aged quartz, results in a 
significant increase in animal lung injury (Lam et al., 2002a,b; Shoemaker et al., 1995). Freshly 
ground quartz has increased reactive silicon-based oxygen radicals, and animals that are exposed 
to freshly ground quartz have been found to have decreased concentrations of antioxidant 
enzymes (Dalal et al., 1990; Vallyathan et al., 1995). Activated quartz particles decay with age in 
ambient air (Dalal et al., 1990). Quartz dusts containing surface iron as an impurity have been 
shown to deplete cellular glutathione, contributing to the oxidative damage that is caused by 
particle and cell-derived reactive oxygen species (Fenoglio et al., 2003). Castranova et al. (1997) 
suggest that freshly ground quartz dust that is contaminated with trace levels of iron may be 
more pathogenic than quartz dust alone. The enhancement of toxicity in quartz by freshly 
fractured surfaces has been consistently observed in animal and cellular systems (Castranova, 
2004; Ding et al., 1999; Porter et al., 2002; Vallyathan et al., 1991). Fracturing silica cleaves the 
Si-O bonds, leaving Si· and SiO· radicals, which, in turn, produce ·OH radicals in an aqueous 
environment. Aged crystalline silica still produces radicals, but at a much lower level, perhaps by 
the Fenton reaction that occurs between iron and H2O2 that is generated by macrophage 
phagocytosis of the particles (Castranova, 2004). 
Crystalline silica exposure studies indicate that the generation of oxidants and nitric 
oxide, that play an important role in the initiation of silicosis (Castranova et al., 2002), has been 
shown to cause pulmonary inflammation in rats (Porter et al., 2002). Other studies indicate that 
the mode of action of cytotoxicity and pathogenicity lies in the ability of the mineral to induce 
lipid peroxidation and protein oxidation and DNA damage (Cerevini-Silva et al., 2014; 
Vallyathan, 1994). Respiratory exposure to freshly ground silica causes greater generation of 
ROS from macrophages than exposure to aged silica, which demonstrates that freshly fractured 
silica is more toxic than aged silica (Porter et al., 2002; Vallyathan et al., 1988). 
Since surface activation, which is produced primarily by grinding, is known to increase 
the toxicity of various mineral dusts, it is essential to ask how quickly surface activation 
disappears once the dust encounters an oxygen and water vapor rich environment. Vallyathan et 
al. (1988) demonstrated a bimodal decay by measuring the rate of disappearance of hydroxyl 
radical formation in an aqueous medium from silicon-based radicals on the surface of ground 
silica, when that ground silica was kept in air until the time of assay. The half-life of the fast 
decay was approximately 30 hours, whereas even after 4 weeks approximately 20% of the 
original activity that was induced by grinding was present on the surface of the quartz. This is 
similar to the ability of the 24-hour half-life in air of freshly fractured quartz to produce ·OH 
radicals (Castranova, 2004). Implicating particle-generated ROS in toxicity requires the 
reconciliation of the relatively brief half-life of this ROS generating reactivity to the lengthy time 
course of the progression of silicosis. The brevity of the time course is inconsistent with a typical 
catalyst that is not consumed in the reaction that it facilitates. Fubini and Hubbard (2003) 
postulate that serial progressions of cellular ingestion cycles, accompanied by a continuous 
recruitment of alveolar macrophages, PMN, and lymphocytes, as the cause of the sustained and 
chronic inflammation elicited by silica. During the sustained inflammation, bronchiolar and 
alveolar epithelial cells are affected by products of oxidatively stressed cells and the particle, 
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resulting in activation and/or cell death. Particle-derived ROS may also react with cell-derived 
ROS and RNS yielding new toxic moieties, e.g., peroxynitrite (ONOO-) from nitric oxide (NO) 
and superoxide anion (O2 •-) (Fubini and Hubbard 2003). This postulate is consistent with 
findings that free radicals and ROS play key roles in the induction of oxidative stress that 
contributes substantially to the toxicity of the particle (Borm et al., 2011). 
It has been recently proposed that an exposure metric that captures the ability of a particle 
to cause oxidative stress may offer advantages over traditional mass concentration measurements 
(Weichenthal et al., 2013). While it has been noted that there is little epidemiological evidence is 
currently available to evaluate the potential benefits of such an approach.” and that the 
conditions of oxidative defenses would need to be taken into account (Weichenthal et al., 2013) 
assessment of the ability of a high fidelity simulant of a celestial dust to induce oxidative stress 
in cells and animals may be a more useful step in assessing its toxicity than projections based 
upon physical features alone. In this regard, however it is important to adhere to the advice 
offered by Donaldson et al. (2009) to be careful in interpretation of in vitro studies. These 
investigators noted that  “three different conventional pathogenic particle types, PM10, asbestos 
and quartz, which cause diverse pathological effects, have been reported to cause very similar 
oxidative stress effects in cells in culture” Donaldson et al. (2009). With this admonition in mind, 
oxidative stress remains a common effect of pathogenic particles of various types, which cause 
diverse pathological effects, and in vitro methods may still serve as useful screening tools to 
refine and reduce animal testing.   
V  COMPUTER-BASED SIMULATION INFORMATION 
This section is not applicable to this risk. 
VI  RISK IN CONTEXT OF EXPLORATION MISSION OPERATIONAL 
SCENARIOS 
Multiple probable scenarios exist in which crew members could be exposed to celestial 
dust during both surface sortie and surface outpost missions. Further, there are opportunities for 
crew members to be directly exposed to celestial dust after they perform EVAs. Post EVA, crew 
members will introduce into the habitat and surface lander the dust that has collected on their 
spacesuits and boots if these items are brought into habitat rather than remaining on a suit port 
exterior to the habitat or vehicle. Cleaning of the suits between EVAs may also directly expose 
crew members to celestial dust. For crew members, changing of ECLSS filters is yet another 
potential route of direct exposure to dusts. These episodic periods of increased dust exposure 
must be taken into account when long-term exposure limits are calculated. As missions become 
longer, the greater dose and/or duration of dust exposure will increase the potential human health 
risk. When a crew returns to microgravity, if dust is introduced into the crew return vehicle, there 
will be an increased opportunity for ocular exposure if particles of dust are floating throughout 
the cabin. EVA activities cause dermal injuries when suits that are based on the current design 
are used, and the introduction of celestial dusts may enhance injuries that will be sustained from 
contact with the EVA suit. In addition, NASA is considering the use of a rover design that will 
allow shirtsleeve operation of the vehicle. Thus, the rover, which must be kept in an interior 
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space to be entered without a spacesuit, may also bring dust into the habitat, which then may be 
inhaled or ingested if food or water are contaminated. 
The site at which various sizes of particles are deposited is critical to an understanding of 
any aspect of their toxic action. Normally, for any dust particles between 10 and 1 µm, the 
portion of particles that is deposited in the upper airways falls off from 80% to 20% as size 
decreases, whereas the pulmonary deposition increases from near zero to about 20%. Pulmonary 
deposition, after falling off near 1 µm, peaks again near 40% for particles of 0.03 µm, whereas 
upper airway deposition remains low until a new peak deposition is found at less than 0.01 µm. 
The portion and pattern of deposition can be modified under conditions of reduced gravity. Data 
collected from humans during flights of the gravity research aircraft show that particles in the 0.5 
to 1 µm range are deposited less in the respiratory system at lunar gravity than at Earth gravity. 
This finding is consistent with the reduced sedimentation of the particles when the gravity is less. 
However, a larger portion of the particles is deposited peripherally (in the alveoli) in reduced 
gravity (Darquenne and Prisk, 2008, Darquenne et al., 2014). 
VII  GAPS 
AEH 1 - What are the unique properties of lunar dust that affect physiology? (Closed) 
Lunar dust particles are unlike terrestrial dusts. Lunar dusts are known to have a high 
surface area and other distinctive shape and chemical characteristics.  
The following tasks have been completed: 
• Lunar Dust - Geology - Geology, Geochemistry and Lithology Science Support 
Activities  
• Lunar Dust - Cell - Study of Lunar Dust and Lunar Simulant Activation, Monitoring, 
Solution and Cellular Toxicity Properties  
AEH 2 - What is the toxicity of lunar dust in the respiratory system?  
During the Apollo missions, anecdotal evidence of respiratory effects of lunar dust were 
reported by crewmembers. However, there is no scientifically defensible data with which to 
assess the toxicity of inhaled lunar dusts. The data to be obtained from the studies described 
below are therefore essential to determining risk criteria and establishing a permissible exposure 
limit for airborne lunar dust.  
Pulmonary toxicity of lunar will be assessed in rodents by intratracheal/intrapharyngeal 
instillation (ITI / IPI) studies and by inhalation studies. In the ITI / IPI studies, groups of rodents 
will be instilled with suspensions of lunar dust and reference dusts (TiO2 and quartz). BALF will 
be assayed for biomarkers of toxicity, and lung tissues will be examined microscopically for 
histopathological lesions. The results of the instillation studies will provide information on the 
toxicity of lunar dust relative to reference dusts whose toxicities are known, and for which 
industrial exposure limits have been established. The ITI / IPI data will also be useful for guiding 
the choice of exposure concentrations for the inhalation study in which markers of toxicity in 
BALF, and histopathology specimens, will be examined. 
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Epidemiological evidence has established associations between exposure to specific types 
of mineral dusts and particular pulmonary pathologies. A common pathway by which exposure 
to mineral dusts leads to pathology involves inflammation and fibrosis. ROS are important 
mediators of inflammation. Therefore cellular toxicity of activated and passivated lunar dusts 
will be evaluated in studies that examine the ability of the respirable size particles to induce 
formation and release of ROS by cells of the respiratory system and to affect secretion of 
mediators of inflammation, such as interleukins 6 and 8 and Tumor Necrosis Factor Alpha, by 
cultured lung cells. Various assays of cell viability will also be utilized. 
The following tasks have been completed: 
• Lunar Dust D/O - Cellular Studies to Support Pulmonary Toxicology Evaluation of 
Lunar Dust, Dermal Studies of Lunar Dust and Ocular Studies of Lunar Dust  
• Lunar Dust-ITI - Pulmonary Toxicity Studies of Lunar Dust in Mice and Rats  
• Lunar Dust - Cell - Study of Lunar Dust and Lunar Simulant Activation, Monitoring, 
Solution and Cellular Toxicity Properties  
• Human Lung Low g - Clearance of Particles Depositing in the Human Lung in Low-
Gravity 
AEH 4 - What is the dermal and ocular toxicity of lunar dust? (Closed) 
During the Apollo missions crews reported irritation of skin and eyes after exposure to 
lunar dust. However, there are no data with which to establish the dermal and ocular toxicity of 
lunar dusts. The determination of the dermal and ocular hazards of lunar dust is necessary to 
predict and prevent any consequence that could result from insults to the integument or cornea 
originating from contact with lunar dust during mission operations. 
The following task has been completed: 
• Lunar Dust D/O - Cellular Studies to Support Pulmonary Toxicology Evaluation of 
Lunar Dust, Dermal Studies of Lunar Dust and Ocular Studies of Lunar Dust 
AEH 5 - What are the permissible exposure limits for inhalation of lunar dust? (Closed) 
Data collected from AEH Gaps 1and 2 will be analyzed to develop a time-based 
concentration exposure limit for airborne lunar dust. The standard will cover 6-month episodic 
exposures, but may include other time-based exposure limits (acute and chronic) contingent upon 
the availability of data. 
The following tasks have been completed: 
• Lunar Dust D/O - Cellular Studies to Support Pulmonary Toxicology Evaluation of 
Lunar Dust, Dermal Studies of Lunar Dust and Ocular Studies of Lunar Dust  
• Lunar Dust - Geology - Geology, Geochemistry and Lithology Science Support 
Activities  
• LDHS - LADTAG Lunar Dust Health Standard  
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• Lunar Dust-ITI - Pulmonary Toxicity Studies of Lunar Dust in Mice and Rats  
• Lunar Dust - Cell - Study of Lunar Dust and Lunar Simulant Activation, Monitoring, 
Solution and Cellular Toxicity Properties  
• Human Lung Low g - Clearance of Particles Depositing in the Human Lung in Low-
Gravity 
AEH 11 - What is the potential for acute or chronic cardiovascular toxicity of lunar dust? 
This gap has been superseded by the gap DUST 11 
DUST-11 - What is the potential for acute toxicity of lunar dust (all relevant endpoints), and 
acute/chronic cardiovascular toxicity of lunar dust?	  	  
Extensive research was performed to establish a permissible exposure limit (PEL) for 
average exposure to lunar dust over the course of a 6-month mission. The gap that remains is to 
determine the acceptable short-term excursions that do not violate the average but may cause 
acute toxicity. 
Specifically, much evidence has been accumulated that demonstrates that the respiratory 
system is not the only system that experiences deleterious effects as a result of inhalation of PM. 
A link between PM in air and cardiovascular morbidity and mortality has been firmly established 
(Pope et al, 2004; Scapellato et al, 2007; Walker and Mouton, 2008). Pope (2008)) reported that 
long-term exposures to PM were most strongly associated with mortality attributable to ischemic 
heart disease, dysrhythmias, heart failure, and cardiac arrest. Oxidative stress initiated in 
response to inhaled particles is thought to lead to inflammation which in turn stimulates release 
from lungs into the circulation of pro-inflammatory mediators that promote systemic 
inflammation that exacerbates or establishes conditions that promote pathology at sites beyond 
the lungs (Seaton et al, 1995). More recently, studies with nanoparticles have indicated that 
effects distal to the lungs may originate locally in response to inhaled PM that has translocated 
from the lungs (Oberdorster et al., 2002, 2004; Nemmar et al., 2004; Borm et al., 2006; 
Mossman et al., 2007; Rothen-Ruthishauser et al., 2007), or by PM affecting respiratory reflexes 
or the autonomic nervous system (Gwin et al., 2006). The observation that inhalation of PM 
produces adverse effects at sites distal to the lungs, and the possibility that some of these effects 
may be caused by translocation of PM, particularly ultrafines, from the lungs, suggests additional 
gaps in the knowledge that we will require to fully assess the risk of adverse health effects posed 
by lunar dust.  
In the LADTAG final report of February 7, 2014 cardiovascular risks were highlighted as 
an area for further risk assessment/research. This assessment was seconded by a recommendation 
received from the Standing Review Panel that AEH include a new gap to assess the potential for 
acute or chronic cardiovascular toxicity of lunar dust. Gap Dust 11 acknowledges those 
recommendations.  
In addition, there is evidence to suggest that celestial dusts have potential allergenic 
properties that may be exacerbated by spaceflight. Several recent studies have provided evidence 
of immune dysregulation during spaceflight (Mehta et al., 2007, 2013; Crucian et al., 2008, 
2009, 2011, 2013), which may contribute to an increased potential for acute hypersensitivity 
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reactions. Symptoms suggestive of an allergic response, which worsened with each exposure, 
were documented in a flight surgeon, who was exposed to lunar dust during post-mission 
handling of EVA suits (Scheuring et al., 2008). 
The following task is Planned-Unfunded: 
• Acute LD Tox - Acute Lunar Dust Toxicology 
DUST-12: We need to determine if technologies are available or need to be developed to evaluate 
celestial dust toxicity and/or volatile composition in situ. 
The current toxicology evaluations for spaceflight use traditional technologies to identify 
toxicants associated with the spaceflight environment. In the toxicology field there are emerging 
“organ on a chip” methodologies that may have merit as a tool in addressing materials toxicity 
(e.g., at the location of an asteroid or on the surface of Mars) rather than in returning samples. 
These new technologies will be critical for the evaluation of spaceflight environments 
exploration class missions provided increased technology with decreased time and mass. If 
sample return is possible, these technologies may also be employed as a relative toxicity 
screening tool to help guide the research needed to establish a PEL and possibly reduce the scope 
of animal testing. 
The following tasks are Planned-Unfunded: 
• Robotic Precursor - Robotic Precursor  
• Organ on a chip - Organ on a chip (Pilot) 
DUST-13: We need to determine if there are significant differences in respiratory, cardiovascular, 
ocular, or dermal toxicity of dusts from different exploration targets or if existing permissible 
exposure limits can be applied. 
Previous research and data mining efforts have focused on the development of the Lunar 
Dust Permissible Exposure Limit (PEL). The Lunar Dust PEL is not meant to be broadly 
applicable to dusts/surface materials at other exploration targets. Once these targets are identified 
and exposure conditions are understood, a risk assessment will likely be required to more fully 
assess how inherent toxicity/exposure conditions necessitate a different PEL (if a PEL is 
determined to be necessary for that location). 
The following tasks are Planned-Funded: 
• Dust Data Mining - Dust Data Mining 
• Martian Dust TIM - Martian Dust Technical Interchange Meeting (TIM) 
The following tasks is Planned-Unfunded: 
• Celestial Dust Ground - Celestial Dust Ground 
DUST-14 - If relative toxicity is unknown and/or significant differences in toxicity do exist, we need 
to understand the acute and chronic toxicities of the celestial dust and/or volatiles in order to 
establish permissible exposure limit.	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The applicability of the Lunar Dust permissible exposure limits (PEL) will be evaluated 
for each mission scenario. If the lunar dust PEL is not appropriate for the mission then a 
comprehensive risk assessment work (potentially on the scale of Lunar Airborne Dust Toxicity 
Advisory Group - LADTAG) may be warranted if significant potential differences in toxicity 
exist such that a target-specific PEL is necessitated. 
There are no tasks currently planned for this gap. 
Addressing these Gaps in our knowledge about features of the dust and its toxicity, will 
allow NASA to establish safe exposure limits to inform the design of habitats and vehicles so 
that exposures of crews to celestial dusts would be limited to safe levels.   
VIII  CONCLUSION 
The evidence literature provides substantial basis for concern that prolonged exposure to 
respirable celestial dust could be detrimental to human health. Celestial bodies where a 
substantial portion of the dust is in the respirable range or where the dusts have large reactive 
surface areas or contain transition metals or volatile organics, represent greater risks of adverse 
effects from exposure to the dust. It is possible that in addition to adverse effects to the 
respiratory system, inhalation and ingestion of celestial dusts could pose risks to other systems.  
32	  
	  
IX  REFERENCES 
Abraham JL, Wiesenfeld SL. (1997) Two cases of fatal PMF in an ongoing epidemic of 
accelerated silicosis in oilfield sandblasters: lung pathology and mineralogy. Annal Occup Hyg 
41:440-447 
Allen RW, Carlsten C, Karlen B, Leckie S, Eeden SV, Vedal S, Wong I, Brauer M. (2011) An 
air filter intervention study of endothelial function among healthy adults in a woodsmoke-
impacted community. American J Resp Crit Care Med 183(9):1222-1230 
Apopa P, Qian Y, Shao R et al. (2009) Iron oxide nanoparticles induce human microvascular 
endothelial cell permeability through reactive oxygen species production and microtubule 
remodeling Part Fibre Toxicol 6(1):1-14 
Araujo J. (2011) Particulate air pollution, systemic oxidative stress, inflammation, and 
atherosclerosis. Air Qual Atmos Health 4:79-93 
Araujo JA, Barajas B, Kleinman M, et al. (2008) Ambient particulate pollutants in the ultrafine 
range promote early atherosclerosis and systemic oxidative stress. Circ Res 102(5):589-596 
Araujo JA, Nel AE. (2009) Particulate matter and atherosclerosis: role of particle size, 
composition and oxidative stress. Part Fibre Toxicol 6(1):24-42 
Araujo, J. A., & Rosenfeld, M. E. (2015). Air Pollution, Lipids and Atherosclerosis. In: Nadadur 
SS, Hollingsworth, JW (eds) Air Pollution and Health Effects. Springer, London, pp. 241-267  
Atreya SK, Wong AS, Renno NO, Farrell WM, Delory GT, Sentman DD, Catling DC. (2006) 
Oxidant enhancement in martian dust devils and storms: implications for life and habitability. 
Astrobiol 6(3):439-450 
Armstrong NA, Aldrin EA, Collins M. (1969) Apollo 11 Technical Crew Debriefing, NASA 
Johnson Space Center, Houston, TX, pp 81 
Ayres JG, Borm P, Cassee FR, et al. (2008) Evaluating the toxicity of airborne particulate matter 
and nanoparticles by measuring oxidative stress potential-a workshop report and consensus 
statement. Inhal Toxicol 20(1):75-99 
Baccarelli A, Zanobetti A, Martinelli I, Grillo P, Hou L, Lanzani G, Mannucci PM, Bertazzi PA, 
Schwartz J. (2007) Air pollution, smoking, and plasma homocysteine. Environ Health Perspect 
115:176-181 
Bastacky J, Lee CYC, Goerke J, et al. (1995) Alveolar lining layer is thin and continuous: Low-
temperature scanning electron microscopy of rat lung. J Appl Physiol 79:1615-1628 
Batsura YD, Kruglikov GG, Arutyunov VD. (1981) Morphology of experimental 
pneumoconiosis following inhalation of lunar soil. Bull Exp Biol Med 92(3):1294-1297 
33	  
	  
Baxter PJ, Ing R, Falk H, French J, Stein GF, Bernstein RS, Merchant JA, Allard J. (1981) 
Mount St Helens eruptions, May 18 to June 12, 1980. An overview of the acute health impact. J 
Am Med Assoc 246:2585-2589 
Baxter PJ, Bonadonna C, Dupree R, Hards VL, Kohn SC, Murphy MD, Nichols A, Nicholson 
RA, Norton G, Searl A, Sparks RSJ, Vickers BP. (1999) Cristobalite in volcanic ash of the 
Soufriere Hills Volcano, Montserrat, British West Indies. Science 283:1142-1145 
Beck BD, Brain JD, Bohannon DE. (1981) The pulmonary toxicity of an ash sample from the 
Mt. St. Helens Volcano. Exp Lung Res 2:289-301 
Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI. (2004) 
Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium 
dioxide particles. Toxicol Sci 77(2):347-357 
Bernstein RS, Baxter PJ, Falk H, Ing R, Foster L, Frost F. (1986) Immediate public health 
concerns and actions in volcanic eruptions: lessons from the Mount St. Helens eruptions. Am J 
Publ Health 76:25-37 
Bhatnagar A. (2006) Environmental cardiology studying mechanistic links between pollution 
and heart disease. Circ Res 99(7):692-705 
Block ML, Calderon-Garciduenas L. Air pollution: mechanisms of neuroinflammation and CNS 
disease. Trends Neurosci 32:506-16 
Borm PJ, Tran L, Donaldson K. (2011) The carcinogenic action of crystalline silica: a review of 
the evidence supporting secondary inflammation-driven genotoxicity as a principal mechanism. 
Crit Rev Toxicol 41(9):756-770 
Braakhuis HM, Par, MV, Gosens I, De Jong WH, Cassee FR. (2014) Physicochemical 
characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol 
11(18):1-25 
Brauner EV, Forchhammer L, Møller P, Simonsen J, Glasius M, Wåhlin P, Raaschou-Nielsen O, 
Loft S. (2007) Exposure to ultrafine particles from ambient air and oxidative stress-induced 
DNA damage. Environ Health Perspect 115:1177-1182 
Burn BR, Varner KJ. (2015) Environmentally persistent free radicals (EPFRs) compromise left 
ventricular function during ischemia/reperfusion injury. Am J Physiol - Heart Circ Physiol 
ajpheart-00891. http://ajpheart.physiology.org/content/early/2015/02/09/ajpheart.00891.2014 
Calderon-Garciduenas L, Solt AC, Henriquez-Roldan C, Torres-Jardon R, Nuse B, Herritt L et 
al. (2008) Long-term air pollution exposure is associated with neuroinflammation, an altered 
innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, 
34	  
	  
and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol 
Pathol 36: 289-310 
Calderon-Garciduenas L, Serrano-Sierra A, Torres-Jardón R, et al. (2013) The impact of 
environmental metals in young urbanites’ brains. Exp Toxicol Pathol 65(5):503-511 
Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT. (2003) Occupational silica 
exposure and risk of various diseases: an analysis using death certificates from 27 states of the 
United States. Occup Environ Med 60(2):122-129 
Carlsen HK, Hauksdottir A, Valdimarsdottir UA, et al. (2012) Health effects following the 
Eyjafjallajökull volcanic eruption: a cohort study. BMJ Open 2:e001851; doi:10.1136/ bmjopen-
2012-001851 
Cassee FR. (2007) Foreword. In: Donaldson K, Borm P, eds. Particle Toxicology. Boca Raton, 
FL: CRC Press Taylor and Francis Group 
Castranova V. (2000) From coal mine dust to quartz: mechanisms of pulmonary pathogenicity. 
Inhal Toxicol 3:7-14 
Castranova V. (2004) Signaling pathways controlling the production of inflammatory mediators 
in response to crystalline silica exposure: Role of reactive oxygen/nitrogen species. Free Radic 
Biol Med 37:916-925 
Castranova V, Pailes WH, Dalal ND, et al. (1996) Enhanced pulmonary response to the 
inhalation of freshly fractured silica as compared with aged dust exposure. Appl Occup Environ 
Hyg 11(7):937-941 
Castranova V, Porter D, Millecchia L, Ma JY, Hubbs AF, Teass A. (2002) Effect of inhaled 
crystalline silica in a rat model: time course of pulmonary reactions. Mol Cell Biochem 
234(1):177-184 
Castranova V, Vallyathan V, Ramsey DM, McLaurin JL, Pack D, Leonard S, Barger MW, 
Ma JY, Dulal NS, Teass A. (1997) Augmentation of pulmonary reactions to quartz inhalation by 
trace amounts of iron containing particles. Environ Health Perspect 105:1319-1324 
Cernan AE, Schmitt HH, Evans RE. (1973) Apollo 17 Technical Crew Debriefing, NASA 
Johnson Space Center, Houston, TX, pp 10-2; 10-6; 10-14; 13-1; 19-11; 27-28; 27-29; 27-47 
Cervini-Silva, J, Gomez-Vidales V, Ramirez-Apan MT, Palacios E, Montoya A, Kaufhold S, 
Abidin Z, Theng BK (2014) Lipid peroxidation and cytotoxicity induced by respirable volcanic 
ash. J Hazard Matl 274:237-246 
Chen W, Liu Y, Wang H, et al. (2012) Long-term exposure to silica dust and risk of total and 
cause-specific mortality in Chinese workers: a cohort study. PLoS Med 9(4):e1001206 
35	  
	  
Cherniack, M. (1986) The Hawk’s Nest incident: America’s worst industrial disaster. Yale 
University Press, New Haven, Conn. 
Choi HS, Ashitate Y, Lee JH, et al. (2010) Rapid translocation of nanoparticles from the lung 
airspaces to the body. Nat Biotechnol 28:1300-1303 
Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. (2007) The effect of urban air pollution on 
inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J 
Respir Crit Care Med 176:370-376 
Cohignac V, Landry MJ, Boczkowski J, Lanone, S. (2014) Autophagy as a possible underlying 
mechanism of nanomaterial toxicity. Nanomaterials 4(3):548-582 
Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS. (2006). Pneumoconiosis: comparison of 
imaging and pathologic findings. Radiographics 2006:26:59-77 
Collier MR, Farrell WM, Stubbs TJ. (2013) The lunar dust pendulum. Adv Space Res 52(2):251-
261 
Conrad C, Gordon Jr RF, Bean AL. (1969) Apollo 12 Technical Crew Debriefing,  NASA 
Johnson Space Center, Houston, TX, pp 10-27; 12-25; 13-8; 13-7 
Cooper BL, McKay DS, Riofrio LM, Taylor LA, Gonzalez CP (2010). Sub-10-micron and 
respirable particles in lunar soils. 41st Lunar and Planetary Science Conference, March 1-5, 
2010, The Woodlands, TX 
Colwell JE, Batiste S, Horányi, M, Robertson S, Sture S. (2007). Lunar surface: Dust dynamics 
and regolith mechanics. Rev Geophys, 45 45, RG2006, doi:10.1029/2005RG000184  
Costa LG, ColeTB, Coburn J, Chang YC, Dao, K, Roque P. (2014) Neurotoxicants are in the air: 
convergence of human, animal, and in vitro studies on the effects of air pollution on the brain. 
BioMed Res Int http://dx.doi.org/10.1155/2014/736385 
Cox LAT Jr. (2011) An Exposure-­‐Response Threshold for Lung Diseases and Lung Cancer 
Caused by Crystalline Silica. Risk Analysis 31(10):1543-1560 
Dalal NS, Shi XL, Vallyathan V. (1990) ESR spin trapping and cytotoxicity investigations of 
freshly fractured quartz: mechanism of acute silicosis. Free Radic Res Comm 9:259-266 
Darquenne C, Borja MG, Oakes JM, Breen EC, Olfert IM, Scadeng M, Prisk GK. (2014) 
Increase in relative deposition of fine particles in the rat lung periphery in the absence of gravity. 
J Appl Physiol 117(8):880-886 
Darquenne C, Prisk GK. (2008) Deposition of inhaled particles in the human lung is more 
peripheral in lunar gravity than in normal gravity. Eur J Appl Physiol 103:687-695 
36	  
	  
Davila AF, Willson D, Coates JD, McKay CP. (2013) Perchlorate on Mars: a chemical hazard 
and a resource for humans. Int J Astrobiology 12(04):321-325 
Delbo M, Libourel G, Wilkerson J, Murdoch N, Michel P, Ramesh KT, Ganino C, Verati C, 
Marchi, S. (2014) Thermal fatigue as the origin of regolith on small asteroids. Nature, 
508(7495):233-236 
Derbyshire E. (2001) Geological hazards in loess terrain, with particular reference to the loess 
regions of China. Earth Sci Rev 54(2001):231-260 
Derbyshire, E. (2007) Natural minerogenic dust and human health. AMBIO 36(1):73-77 
Derbyshire E, Horwell CJ, Jones TP, Tetley TD. (2012) Airborne particles. In: Plant JA, 
Voulvoulis N, Ragnarsdottir KV (eds) Pollutants, Human Health and the Environment: A Risk-
Based Approach, 1st edn. Wiley, New York, pp 255-286 
Dietz A, Ramroth H, Urban T, Ahrens W, Becher H. (2004) Exposure to cement dust, related 
occupational groups and laryngeal cancer risk: Results of a population based case-­‐control study. 
Int J Cancer 108(6):907-911 
Ding M, Shi X, Dong Z, Chen F, Lu Y, Castranova V, Vallyathan V. (1999) Freshly fractured 
crystalline silica induces activator protein-1 activation through ERKs and p38 MAPK.  J Biol 
Chem 274(43):30611-30616 
Dodson RF, Shepherd S, Levin J, Hammar SP. (2007) Characteristics of the asbestos 
concentration in the lung as compared to asbestos concentration in various levels of lymph nodes 
that collect drainage from the lung. Ultrastruct Pathol 31:95-133 
Donaldson K, Borm P. (1998) The quartz hazard: a variable entity. Ann Occup Hyg 42(5):287-
294 
Donaldson K, Duffin R, Langrish JP et al. (2013) Nanoparticles and the cardiovascular system: a 
critical review. Nanomed 8(3):403-423 
Donaldson K, Poland CA. (2013) Nanotoxicity: challenging the myth of nano-specific toxicity. 
Curr Opin Biotech, 24(4):724-734 
Donaldson K, Stone V, Duffin R, Clouter A, Schins R, Borm P. (2001) The quartz hazard: 
effects of surface and matrix on inflammogenic activity. J Environ Pathol Toxicol Oncol. 20 
Suppl 1:109-118 
Downs, R. T. (2015). Determining Mineralogy on Mars with the CheMin X-Ray Diffractometer. 
Elements, 11(1), 45-50. 
37	  
	  
Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H, Schlesinger RB. (2000) 
Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: 
uses and limitations. Toxicol Sci 55(1):24-35 
Driscoll K, Guthrie G. (1997) Crystalline silica and silicosis. In: Comprehensive Toxicology, 
Vol. 8. Toxicology of the Respiratory System. Sipes I, McQueen C, Gandolfi A, Roth R (Eds.). 
Elsevier Science Inc, N.Y., pp 373-391 
Elder A, Gelein R, Silva et al. (2006) Translocation of inhaled ultrafine manganese oxide 
particles to the central nervous system. Environ Health Perspect 114:1172-1178 
Erren TC, Glende CB, Morfeld P, Piekarski C. (2009) Is exposure to silica associated with lung 
cancer in the absence of silicosis? A meta-analytical approach to an important public health 
question. Int Arch Occup Environ Health 82:997-1004 
Fenoglio I, Fonsato S, Fubini B. (2003) Reaction of cysteine and glutathione (GSH) at the 
freshly fractured quartz surface: a possible role in silica-related diseases. Free Radic Biol Med 
35(7):752-762 
Fenoglio I, Martra G, Prandi L, Tomatis M, Coluccia S, Fubini B. (2000) The role of 
mechanochemistry in the pulmonary toxicity caused by particulate minerals. J Material Syn Proc 
8(3/4):145-153 
Forbes L, Jarvis D, Pots J, Baxter P. (2003) Volcanic ash and respiratory symptoms in children 
on the island of Montserrat, British West Indies. Occup Environ Med 60:207-211 
Fortunato L, Rushton L. (2015) Stomach cancer and occupational exposure to asbestos: a meta-
analysis of occupational cohort studies. Brit J Cancer doi:10.1038/bjc.2014.599  
Fubini B. (1998) Surface chemistry and quartz hazard. Ann Occup Hyg 42(8):521-530 
Fubini B. (2002) V. Chemical reactivity of the quartz surface in relation to its toxicity and 
genotoxicity. In Schneider WD. 2002 Quarz. Einstufung, Dosis-Wirkungs-Beziehungen. 
Workshop vom 07./08. März 2002 in Berlin. Dortmund/Berlin/Dresden 
http://www.baua.de/cae/servlet/contentblob/697144/publicationFile/46888/ 
Garcia RF, Murdoch N, Mimoun D. (2015) Micro-meteoroid seismic uplift and regolith 
concentration on kilometric scale asteroids. Icarus 253:159-168 
García-Pérez J, López-Abente G.,Castelló A, González-Sánchez M, Fernández-Navarro, P. 
(2015) Cancer mortality in towns in the vicinity of installations for the production of cement, 
lime, plaster, and magnesium oxide. Chemosphere 128:103-110 
38	  
	  
Gasser M, Riediker M, Mueller L, Perrenoud A, Blank F, Gehr, P, Rothen-Rutishauser B. (2009) 
Toxic effects of brake wear particles on epithelial lung cells in vitro. Part Fibre Toxicol 6(30):1-
13 
Geiser M, Kreyling WG. (2010) Deposition and biokinetics of inhaled nanoparticles. Part Fibre 
Toxicol, 7(2):1-17 
Ghelfi E. (2011) Air pollution, reactive oxygen species (ROS), and autonomic nervous system 
interactions modulate cardiac oxidative stress and electrophysiological changes. INTECH Open 
Access Publisher. 
Ghiazza M, Polimeni M, Fenoglio I, Gazzano E, Ghigo D, Fubini B. (2010). Does vitreous silica 
contradict the toxicity of the crystalline silica paradigm?  Chem Res Toxicol 23:6. 
Gilmour PS, Morrison ER, Vickers MA, Ford I, Ludlam CA, Greaves M, Donaldson K, MacNee 
W (2005) The procoagulant potential of environmental particles (PM10). Occup Environ Med 
62:164 -171 
Glotch TD, Lucey PG, Bandfield JL, et al. (2010) Highly silicic compositions of the moon. 
Science 329:1510-153 
Gray DL, Wallace LA, Brinkman MC, Buehler SS, La Londe C. (2015) Respiratory and 
Cardiovascular Effects of Metals in Ambient Particulate Matter: A Critical Review. In: Whitacre, 
DR (ed) Reviews of environmental contamination and toxicology, Springer International 
Publishing, Cham, Heidelberg, New York, Dordrecht, London, pp. 135-203 
Greenhagen BT, Lucey PG, Wyatt MB et al.  (2010) Global silicate mineralogy of the Moon 
from the Diviner Lunar Radiometer. Science 329(5998):1507-1509 
Gutherie Jr GD. (1997) Mineral properties and their contributions to particle toxicity. Environ 
Health Perspect 105 (Suppl5):1003-1011 
Gwinn MR, Vallyathan V. (2006) Nanoparticles: health effects: pros and cons. Environ Health 
Perspect 114:1818-1825 
Holland JW, Simmonds RC. (1973) The mammalian response to lunar particulates. Space Life 
Sci 4:97-109 
Horwell CJ. (2007) Grain-size analysis of volcanic ash for the rapid assessment of respiratory 
health hazard. J Environ Monit 9:1107-1115 
Horwell, CJ, Baxter PJ, Hillman SE, et al. (2013) Physicochemical and toxicological profiling of 
ash from the 2010 and 2011 eruptions of Eyjafjallajökull and Grímsvötn volcanoes, Iceland 
using a rapid respiratory hazard assessment protocol. Environ Res 127:63-73 
39	  
	  
Horwell CJ, Damby DE, Hillier S. (2015) Respirable volcanic ash is distinct mineralogically, 
physicochemically and toxicologically from soils originating from weathered volcanic products. 
A comment on Cervini-Silva et al. (2014)" Lipid peroxidation and cytotoxicity induced by 
respirable volcanic ash" J Hazard Matl 285:366-377 
Ichinose T, Yoshida S, Sadakane K, et al. (2008) Effects of Asian sand dust, Arizona sand dust, 
amorphous silica, and aluminum oxide on allergic inflammation in the murine lung. Inhal 
Toxicol 20:685-694 
International Agency for Research on Cancer. (1997) IARC Monographs on the Evaluation of 
Carcinogenic Risks to Humans, Vol. 68, Silica, some silicates, coal dust and para-aramid fibrils. 
Lyon: International Agency for Research on Cancer.  
James JT, Lam C-W, Santana P, Scully RR. (2013) Estimate of safe human exposure levels for 
lunar dust based on comparative benchmark dose modeling. Inhal. Toxicol. 25:243-256 
Jaumann R, Hiesinger H, Anand M, et al. (2012). Geology, geochemistry, and geophysics of the 
Moon: Status of current understanding. Planet Space Sci 74(1):15-41 
Jones K, Morton J, Smith I, Jurkschat K, Harding AH, Evans G. (2015) Human in vivo and in 
vitro studies on gastrointestinal absorption of titanium dioxide nanoparticles. Tox Lett 233(2):95-
101 
Jones L, Jacques S, Tranfield S, Rask J, Kerschmann, R, Loftus D, Taylor L. (2009) NASA 
Human Research Program Investigators' Workshop, Feb 2-4, League City, TX 
Jones T, BéruBé K. (2007) Chapter 2. Mineralogy and structure of pathogenic particles. In: 
Donaldson K, Borm P, eds. Particle Toxicology. CRC Press Taylor and Francis Group, Boca 
Raton, FL pp 13-45  
Kajiwara T, Ogami A, Yamato H, Oyabu T, Morimoto Y, Tanaka I. (2007). Effect of particle 
size of intratrachaeally instilled crystalline silica on pulmonary inflammation. J Occup Health 
49:88-94 
Kampfrath T, Maiseyeu A, Ying Z, et al. (2011) Chronic fine particulate matter exposure induces 
systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res 108(6):716-
726 
Kendall M, Brown L, Trought K. (2004) Molecular adsorption at particle surfaces: A PM 
toxicity mediation mechanism. Inhal Toxicol 16(Suppl.1):99-105 
Khan-Mayberry NN (2008). The lunar environment: Determining the health effects of exposure 
to moon dusts. Acta Astronaut 63 (7-10):1006-1014 
40	  
	  
Kleiger RE, Miller JP, Bigger JT Jr., Moss AJ. (1987) Decreased heart rate variability and its 
association with increased mortality after acute myocardial infarction. Am J Cardiol 59, 256-262 
Kuempel ED, Smith RJ, Dankovic DA, Stayner LT. (2009) Rat-and human-based risk estimates 
of lung cancer from occupational exposure to poorly-soluble particles: a quantitative evaluation. 
J Physics: Conf Series 151 (1):012011.  doi:10.1088/1742-6596/151/1/012011 
Kreyling WG, Scheuch G. (2000) Chapter 7: Clearance of Particles Deposited in the Lungs. In: 
Gehr P, Heyder J, (eds) Particle-Lung Interactions, Marcel Dekker, Inc., New York -Basel, pp 
323-376 
Kreyling WG, Semmler-Behnke M, Möller W. (2006) Ultrafine particle-lung interactions: does 
size matter? J Aerosol Med 19(1):74-83 
Kustov VV, Ostapvenko OF, Petrukhin VG. (1974) [Research on the biological effect of a fine 
fraction of lunar soil sent to Earth by the unmanned station Luna-16]. In: [Lunar Soil from the 
Sea of Fertility]. Moscow: M. Nauka, 592 
Kustov VV, Belkin VI, Kruglikov GG. (1989) [Biological effects of lunar soil]. [Problems in 
Space Biology] 61:1-146 
Lam CW, James JT, McCluskey R, Cowper S, Balis J, Muro-Cacho C. (2002a) Pulmonary 
toxicity of simulated lunar and Martian dusts in mice: I. Histopathology 7 and 90 days after 
intratracheal instillation. Inhal Toxicol, 14:901-916 
Lam CW, James JT, Latch JN, Hamilton RF Jr, Holian, A. (2002b). Pulmonary toxicity of 
simulated lunar and Martian dusts in mice: II. Biomarkers of acute responses after intratracheal 
instillation. Inhal Toxicol 14(9):917-928 
Lam CW, Scully RR, Zhang Y, et al. (2013). Toxicity of lunar dust assessed in inhalation-
exposed rats. Inhalation Toxicol 25:661-678 
Langley RJ, Kalra R, Mishra NC, Hahn FF, Razani-Boroujerdi S, Singh SP, Benson JM, Pena- 
Philippides JC, Barr EB, Sopori ML. (2004) A biphasic response to silica: I. Immunostimulation 
is restricted to the early stage of silicosis in Lewis rats. Am J Respir Cell Mol Biol 30:823-829 
Langley RJ, Mishra NC, Pena-Philippides JC, Hutt JA, Sopori ML. (2010) Granuloma formation 
induced by low-dose chronic silica inhalation is associated with an anti-apoptotic response in 
Lewis rats. J Toxicol Environ Health A. 73:669-683 
Langley RJ, Mishra NC, Peña-Philippides JC, Rice BJ, Seagrave JC, Singh SP, Sopori ML. 
(2011) Fibrogenic and redox-related but not proinflammatory genes are upregulated in Lewis rat 
model of chronic silicosis. J Toxicol Environ Health A 74(19):1261-1279 
41	  
	  
Latch JN, Hamilton Jr RF, Holian A, Lam C, James JT. (2008) Toxicity of lunar and Martian 
dusts simulants to alveolar macrophages isolated from human volunteers. Inhal Toxicol 20:1-9 
Lippmann M, Yeates, DB, Albert RE. (1980). Deposition, retention, and clearance of inhaled 
particles. Br J Indust Med 37(4):337-362 
Liu Y, Park J, Schnare D, Hill E, Taylor LA. (2008) Characterization of lunar dust for 
toxicological studies. II: Texture and shape characteristics. J Aerosp Eng 21(4):272-279 
Liu Y, Taylor LA. (2011) Characterization of lunar dust and a synopsis of available lunar 
simulants. Planet Space Sci 59(14):1769-1783 
López-Villarrubia E, Ballester F, Iñiguez C, Peral N. (2010) Air pollution and mortality in the 
Canary Islands: a time-series analysis. Environ Health 9(8):1-11 
Lo Re S, Dumoutier L, Couillin I, et al. (2010) IL-17A-producing γδ T and Th17 lymphocytes 
mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol 184:6367-6377 
MacNicoll A, Kelly M, Aksoy H, Kramer E, Bouwmeester H, Chaudhry Q. (2015). A study of 
the uptake and biodistribution of nano-titanium dioxide using in vitro and in vivo models of oral 
intake. J Nanopart Res 17(2):1-20 
Mallone S, Stafoggia M, Faustini A, Paolo Gobbi G, Marconi A, Forastiere F. (2011) Saharan 
dust and associations between particulate matter and daily mortality in Rome, Italy. Environ Hlth 
Perspect 119(10):1409-1414 
Martin TR, Ayars G, Butler J, Altman LC. (1984) The comparative toxicity of volcanic ash and 
quartz. Effects on cells derived from the human lung. Am Rev Respir Dis 130(5):778-78 
Martin TR, Wehner AP, Butler J. (1986) Evaluation of physical health effects due to volcanic 
hazards: the use of experimental systems to estimate the pulmonary toxicity of volcanic ash. Am 
J Publ Health 76:59-65 
Matsumoto T, Tsuchiyama A,  Miyake A, et al. (2014) Surface Micromorphologies of Regolith 
Particles from Asteroid Itokawa and Its Implication to Space Weathering. LPI Contributions, 
1800, 5130. 
Mauderly JL. (1997) Relevance of particle-induced rat lung tumors for assessing lung 
carcinogenic hazard and human lung cancer risk. Environmental Health Perspectives, 105(Suppl 
5):1337-1346 
Maynard RL. (2015) The effects on health of ambient particles: time for an agonizing 
reappraisal? Cell Biol Toxicol DOI 10.1007/s10565-015-9296-7 
42	  
	  
McGlynn IO, Fedo CM, McSween HY. (2011) Origin of basaltic soils at Gusev crater, Mars, by 
aeolian modification of impact-­‐generated sediment. J Geophys Res116:E00F22, 
doi:10.1029/2010JE003712. 
McKay DS, Cooper BL, Taylor LA, James JT, Thomas-Keprta K, Pieters C M, Wentworth SJ, 
Wallace WT, Lee, T. S. (2015). Physicochemical properties of respirable-size lunar dust. Acta 
Astro 107:163-176 
Meyer C. (2011) Lunar soil compendium. Available at: 
http://ntrs.nasa.gov/archive/nasa/casi.ntrs.nasa.gov/20090041867.pdf 
Meyers VE, Garcia HD, Monds K, Cooper BL, James JT. Ocular toxicity of authentic lunar dust. 
BMC Ophthalmol 12:26-33 
Miller MR, Borthwick SJ, Shaw CA, et al. (2009) Direct impairment of vascular function by 
diesel exhaust particulate through reduced bioavailability of endothelium-derived nitric oxide 
induced by superoxide free radicals. Environ Health Perspect 117(4):611-6 
Miller MR, Shaw CA, Langrish JP. (2012) From particles to patients: oxidative stress and the 
cardiovascular effects of air pollution. Future Cardiol 8(4):577-602 
Mills NL, Törnqvist H, Robinson SD, Gonzalez MC, Söderberg S, Sandström T, Blomberg A, 
Newby DE, Donaldson, K. (2007) Air pollution and atherothrombosis. Inhal Toxicol, 19(S1):81-
89 
Monick MM, Baltrusaitis J, Powers LS, et al. (2013) Effects of Eyjafjallajokull volcanic ash on 
innate immune system responses and bacterial growth in vitro. Environ Hlth Perspect (6):691-
698 
Morman SA, Plumlee GS. (2013) The role of airborne mineral dusts in human disease. Aeolian 
Res 9:203-212 
Morris RV, Klingelhofer G, Schroder C, et al. (2006). Mineralogy of rock, soil, and dust at 
Meridiani Planum, Mars: opportunity’s journey across sulfate-rich outcrop, basaltic sand dust, 
and hematite lag deposits.  J Geophy Res 111:E12S15, doi:10.1029/2006JE002791 
Morrow PE. (1988). Possible mechanisms to explain dust overloading of the lungs. Fundam 
Appl Toxicol 10(3):369-84 
Murdoch N, Sanchez P, Schwartz SR, Miyamoto H. (2015) Asteroid Surface Geophysics. arXiv 
preprint arXiv:1503.01931 
Nania, J, Bruya TE. (1982) In the wake of Mount St. Helens. Ann Emerg Med 11:184-191 
Nathan CF. (1987) Neutrophil activation on biological surfaces. Massive secretion of hydrogen 
peroxide in response to products of macrophages and lymphocytes. J Clin Invest 80:1550-1560 
43	  
	  
 
National Aeronautics and Space Administration (2011) Voyages Charting the Course for 
Sustainable Human Space Exploration.  NP-2011-06-395-LaRC.  Accessed 11-March-2015 at 
http://www.nasa.gov/sites/default/files/files/ExplorationReport_508_6-4-12.pdf 
National Aeronautics and Space Administration (2015) Human Research Roadmap. Accessed 
28-April-2015 at http://humanresearchroadmap.nasa.gov/Gaps/gap.aspx?i=295 
National Research Council (NRC). (1998) Research Priorities for Airborne Particulate Matter, 
Vol. I. National Academy Press, Washington, D.C. 
Napierska D, Thomassen LCJ, Lison D, Martens JA, Hoet PH. (2010) The nanosilica hazard: 
another variable entity. Particle Fibre Toxicol 7:39 
Nel A, Xia T, Mädler L, Li N. (2006) Toxic potential of materials at the nanolevel. Science 
311:622-627 
Nemmar A, Hoylaerts MF, Hoet PH, Nemery B (2004) Possible mechanisms of the 
cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. 
Toxicology letters 149(1) 243-253 
National Research Council. (2004) Research Priorities for Airborne Particulate matter, Vol. IV. 
National Academy Press, Washington, D.C. 
Nurkiewicz TR, Porter DW, Barger M,  et al. (2006) Systemic microvascular dysfunction and 
inflammation after pulmonary particulate matter exposure. Environ Hlth Perspect 114:412-419 
Oberdorster G, Morrow PE, Spurny K. (1988) Size dependent lymphatic short-term clearance of 
amosite fibers in the lung. Ann Occup Hyg 32(suppl. 1):149-156 
Oberdorster G, Oberdorster E, Oberdorster J. (2005) Nanotoxicology: An emerging discipline 
evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839 
Oberdörster G, Sharp Z, Atudrei V, et al. (2002) Extrapulmonary translocation of ultrafine 
carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 
65:1531-1543 
Oberdörster G, Sharp Z, Atudrei V, et al. (2004) Translocation of inhaled ultrafine particles to 
the brain. Inhal Toxicol 16:437-445 
Occupational Safety & Health Administration. Permissible exposure limits available at 
https://www.osha.gov/dsg/annotated-pels/tablez-1.html  Accessed 12 March 2015 
Ogunbileje JO., Sadagoparamanujam VM, Anetor JI, Farombi EO, Akinosun OM, Okorodudu 
AO. (2013) Lead, mercury, cadmium, chromium, nickel, copper, zinc, calcium, iron, manganese 
44	  
	  
and chromium (VI) levels in Nigeria and United States of America cement dust. Chemosphere, 
90(11):2743-2749 
Olenchock SA, Mull JC, Mentnech MS, Lewis DM, Bernstein RS. (1983) Changes in humoral 
immunologic parameters after exposure to volcanic ash. J Toxicol Environ Health 11:395-404 
Ovrevik J, Myran T, Refsnes M, Låg, M, Becher R, Hetland RB, Schwarze PE. (2005) Mineral 
particles of varying composition induce differential chemokine release from epithelial lung cells: 
importance of physico-chemical characteristics. Ann Occup Hyg, 49(3), 219-231 
Park J, Liu Y, Kihm KD, Taylor LA. (2008) Characterization of lunar dust for toxicological 
studies. I: Particle size distribution. J Aerosp Eng 21(4):266-271 
Park SK, O’Neill MS, Vokonas PS, Sparrow D, Spiro A 3rd, Tucker KL, Suh H, Hu H, Schwartz 
J. (2008) Traffic-related particles are associated with elevated homocysteine: the VA normative 
aging study. Am J Respir Crit Care Med 178:283-289 
Pauluhn J. (2011) Poorly soluble particulates: searching for a unifying denominator of 
nanoparticles and fine particles for DNEL estimation. Toxicology 279(1):176-188 
Pauluhn J. (2012) Subchronic inhalation toxicity of iron oxide (magnetite, Fe3O4) in rats: 
pulmonary toxicity is determined by the particle kinetics typical of poorly soluble particles. J 
Appl Toxicol 32(7):488-504 
Pelucchi C, Pira E, Piolatto G, Coggiola M, Carta P, La Vecchia C. (2006). Occupational silica 
exposure and lung cancer risk: a review of epidemiological studies 1996-2005. Annal Oncol 
17(7):1039-1050 
Perez CM, Hazari MS, Farraj AK. (2015) Role of autonomic reflex arcs in cardiovascular 
responses to air pollution exposure. Cardiovasc Toxicol 15:69-78 
Pieters CM. (1986) Composition of the lunar highland crust from near-infrared spectroscopy. 
Rev Geophys 24(3):557-578 
Pieters CM, Ammannito E, Blewett DT, et al. (2012) Distinctive space weathering on Vesta from 
regolith mixing processes.  Nature 491:79-82 
Porter DW, Barger M, Robinson VA, Leonard SS, Landsittel D, Castranova V. (2002) 
Comparison of low doses of aged and freshly fractured silica on pulmonary inflammation and 
damage in the rat. Toxicol 175:63-71 
Pope CA, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. (2004). 
Cardiovascular mortality and long-term exposure to particulate air pollution epidemiological 
evidence of general pathophysiological pathways of disease. Circulation 109(1):71-77 
45	  
	  
Pope CA, Dockery DW. (2006) Health effects of fine particulate air pollution: lines that connect. 
J Air Waste Manage Assoc 56:709-42 
Pope CA, Renlund DG, Kfoury AG, May HT, Horne BD (2008) Relation of heart failure 
hospitalization to exposure to fine particulate air pollution. Am J Cardiol 102(9):1230-1234 
Price HD, Jones TP, BéruBé KA. (2014) Resolution of the mediators of in vitro oxidative 
reactivity in size-segregated fractions that may be masked in the urban PM 10 cocktail. Sci Total 
Environ 485:588-595 
Raub JA, Hatch GE, Mercer RR, Grady M, Hu PC. (1985) Inhalation studies of Mt. St. Helens 
volcanic ash in animals. II. Lung function, biochemistry, and histology. Environ Res 37:72-83 
Renno NO, Kok JF. (2008) Electrical activity and dust lifting on Earth, Mars, and beyond. In 
Planetary Atmospheric Electricity. Springer, New York, pp. 419-434 
Rich DQ, Kipen HM, Huang W et al. (2012) Association between changes in air pollution levels 
during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young 
adults. JAMA, 307(19):2068-2078 
Riediker M, Cascio WE, Griggs TR, Herbst MC, Bromberg PA, Neas L, Williams RW, Devlin 
RB. (2004) Particulate matter exposure in cars is associated with cardiovascular effects in 
healthy young men. Am J Respir Crit Care Med 169:934 -940 
Roller M. (2009) Carcinogenicity of inhaled nanoparticles. Inhal Toxicol 21(S1):144-157 
Romieu I, Garcia-Esteban R, Sunyer J, Rios C, Alcaraz-Zubeldia M, Velasco SR, Holguin F. 
(2008) The effect of supplementation with omega-3 polyunsaturated fatty acids on markers of 
oxidative stress in elderly exposed to PM(2.5). Environ Health Perspect 116:1237-1242 
Rowe WJ. (2007). Moon dust may simulate vascular hazards of urban pollution. J British 
Interplanet Soc 60:133-136 
Rowe, WJ. (2013). Moon walkers and urban pollution. Am J Med 126(7):e1-e2 
Rothen-Rutishauser B, Muhlfeld C, Blank F, Musso C, Gehr P (2007) Translocation of particles 
and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial 
airway model. Part Fibre Toxicol 4(9) doi:10.1186/1743-8977-4-9 
Sager TM, Kommineni C, Castranova V. (2008) Pulmonary response to intratracheal instillation 
of ultrafine versus fine titanium dioxide: role of particle surface area. Part Fibre Toxicol 5:17  
doi:10.1186/1743-8977-5-17 
Sarkozi L, Horvath E, Konya Z, Kiricsi I, Szalay B, Vezer T, Papp A. (2009) Subacute 
intratracheal exposure of rats to manganese nanoparticles: Behavioral, electrophysiological, and 
general toxicological effects. Inhal Toxicol 21:83-91 
46	  
	  
Scapellato ML, Lotti M. (2007) Short-term effects of particulate matter: an inflammatory 
mechanism? CRC Crit Rev Toxicol 37(6):461-487 
Schaumann F, Borm PJ, Herbrich A, et al. 2004 Metal-rich ambient particles (particulate matter 
2.5) cause airway inflammation in healthy subjects. Am J Respir Crit Care Med 170:898-903 
Schettler T. (2005). Heart Disease and the Environment.  Accessed 21-April-2015 at 
http://www.healthandenvironment.org/cardiovascular 
Scheuring RA, Jones JA, Novak JD, Polk JD, Gillis DB, Schmid, J, Duncan JM, Davis JR. 
(2008) The Apollo Medical Operations Project: Recommendations to Improve Crew Health and 
Performance for Future Exploration Missions and Lunar Surface Operations. Acta Astronaut 
63:980-987 
Schlesinger RB, Kunzli N, Hidy GM, et al. (2006) The health relevance of ambient particulate 
matter characteristics: Coherence of toxicological and epidemiological inferences. Inhal Toxicol 
18:95-125 
Schoonen MA, Cohn CA, Roemer E, Laffers R, Simon SR, O’Riordan T. (2006) Mineral-
induced formation of reactive oxygen species. Rev Minerol Geochem 64(1):179-221 
Schuerger, AC, Golden D C, Ming DW. (2012) Biotoxicity of Mars soils: 1. Dry deposition of 
analog soils on microbial colonies and survival under Martian conditions. Planet Space Sci 
72(1):91-101 
Schürch S, Gehr P, Hof VI, Geiser M, Green F. 1990. Surfactant displaces particles toward the 
epithelium in airways and alveoli. Resp Physiol 80:17-32 
Schwarze PE, Ovrevik J, Hetland RB, Becher R, Cassee FR, Låg M,  Refsnes M. (2007) 
Importance of size and composition of particles for effects on cells in vitro. Inhal Toxicol 
19(S1):17-22 
Scott DR, Irwin JB, Worden AM. (1971) Apollo 15 Technical Crew Debriefing, NASA Johnson 
Space Center, Houston, TX, pp 10-18; 10-21; 10-22 
Scully RR, Lam C-W, James JT. (2013) Estimating safe human exposure levels for lunar dust 
using benchmark dose modeling of data from inhalation studies in rats. Inhal Toxicol 
25(14):785-793 
Simkó M, Mattsson MO. (2010). Risks from accidental exposures to engineered nanoparticles 
and neurological health effects: a critical review. Part Fibre Toxicol 7(42):1-8 
Sheehan, T. (1975) Apollo Program Summary Report. JSC-09423, NASA Johnson Space Center, 
Houston. 
47	  
	  
Shepard AB, Mitchell ED, Roosa SA (1971). Apollo 14 Technical Crew Debriefing NASA 
Johnson Space Center, Houston, TX, pp 9-17; 10-60; 13-3; 13-4 
Shoemaker DA, Pretty JR, Ramsey DM, McLaurin JL, Khan A, Teass AW, Castranova V, Pailes 
WH, Dalal NS, Miles PR. (1995) Particle activity and in vivo pulmonary response to freshly 
milled and aged alpha quartz. Scand J Work Environ Health 21:15-18 
Sørensen M, Daneshvar B, Hansen M, Dragsted LO, Hertel O, Knudsen L, Loft S. (2003) 
Personal PM2.5 exposure and markers of oxidative stress in blood. Environ Health Perspect 
111:161-166 
Stahlhofen W, Scheuch G, Bailey MR. (1995) Investigations of retention of inhaled particles in 
the human bronchial tree. Rad Protect Dos 60 (4):311-319 
Surface Properties of the moon.  Accessed 13-March-2015 at 
http://csep10.phys.utk.edu/astr161/lect/moon/moon_surface.html 
Tassinari R, Cubadda F, Moracci G, Aureli F, D'Amato M, Valeri M, Maranghi F. (2014) Oral, 
short-term exposure to titanium dioxide nanoparticles in Sprague-Dawley rat: focus on 
reproductive and endocrine systems and spleen. Nanotoxicol 8(6):654-662 
Taylor LA, Pieters CM, Keller LP, Morris RV, McKay DS. (2001) Lunar mare soils: Space 
weathering and the major effects of surface-correlated nanophase Fe. J Geophys Res 106 
E11:27985-27999 
Taylor LA, Pieters C, Patchen A, Taylor DHS, Morris RV, Keller LP, McKay DS. (2010) 
Mineralogical and chemical characterization of lunar highland soils: insights into the space 
weathering of soils on airless bodies, J. Geophys. Res. 115 
Theriot CA., Glass A, Lam CW, James J, Zanello SB. (2014) Chronic Lunar Dust Exposure on 
Rat Cornea: Evaluation by Gene Expression Profiling. NASA Human Research Program 
Investigators' Workshop, Feb 12-13, Galveston, TX 
Tobías A, Pérez L, Díaz J, Linares C, Pey J, Alastruey A, Querol X. (2011) Short-term effects of 
particulate matter on total mortality during Saharan dust outbreaks: a case-crossover analysis in 
Madrid (Spain). Sci Total Environ 412:386-389 
Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. (2000) Inhalation of poorly 
soluble particles. II. Influence of particle surface area on inflammation and clearance Inhal 
Toxicol 12(12):1113-1126 
Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL., Levy D. (1994) 
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart 
Study. Circulation 90:878−883 
48	  
	  
US EPA. (2015). Benchmark Dose Software. Available from: http://www.epa.gov/ncea/bmds/ 
accessed 27 Apr 2015 
Vallyathan V. (1995) Generation of oxygen radicals by minerals and its correlation to 
cytotoxicity. Environ Health Perspect 102:111-115 
Vallyathan V, Shi XL, Dalal NS, Irr W, Castranova V. (1988) Generation of free radicals from 
freshly fractured silica dust: Potential role in acute silica-induced lung injury. Am Rev Respir 
Dis 138:1213-1219 
Vallyathan V, Kang JH, Van Dyke K, Dalal NS, Castranova V. (1991) Response of alveolar 
macrophages to in vitro exposure to freshly fractured versus aged silica dust: The ability of 
Prosil 28, an organosilane material, to coat silica and reduce its biological reactivity. J Toxicol 
Environ Health 33:303-315 
Vallyathan V, Castranova V, Pack D, Leonard S, Shumaker J, Hubbs AF, Shoemaker DA, 
Ramsey DM, Pretty JR, McLaurin JL. (1995) Freshly fractured quartz inhalation leads to 
enhanced lung injury and inflammation. Potential role of free radicals. Am J Respir Crit Care 
Med 152:1003-1009 
Verma V, Shafer MM. Schauer JJ, Sioutas C. (2010) Contribution of transition metals in the 
reactive oxygen species activity of PM emissions from retrofitted heavy-duty vehicles. 
Atmospheric Environment, 44(39):5165-5173 
Vinzents PS, Møller P, Sørensen M, Knudsen LE, Hertel O, Jensen FP,  Schibye B, Loft S. 
(2005) Personal exposure to ultrafine particles and oxidative  DNA damage. Environ Health 
Perspect 113:1485-1490 
Wagner SA. (2006) The Apollo Experience Lessons Learned for Constellation Lunar 
Dust Management. TP-2006-213726, Johnson Space Center, Houston, Available on line at: 
http://ston.jsc.nasa.gov/collections/TRS/_techrep/TP-2006-213726.pdf  
Walker B Jr, Mouton CP. (2008) Environmental influences on cardiovascular health. J Natl Med 
Assoc. 100(1):98-102 
Wallace WT, Taylor LA, Liu Y, Cooper BL, McKay DS, Chen B, Jeevarajan AS. (2009) Lunar 
dust and lunar simulant activation and monitoring. Meteorit Planet Sci 44:961-970  
Wang J, Liu Y, Jiao F, et al. (2008) Time dependent translocation and potential impairment on 
central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicol 254:82-90 
Wang J, Zhou G, Chen C, et al. (2007). Acute toxicity and biodistribution of different sized 
titanium dioxide particles in mice after oral administration. Tox Lett 168(2):176-185 
49	  
	  
Warheit DB, Donne EM. (2015) How meaningful are risk determinations in the absence of a 
complete dataset? Making the case for publishing standardized test guideline and ‘no effect’ 
studies for evaluating the safety of nanoparticulates versus spurious ‘high effect’ results from 
single investigative studies. Sci Technol Adv Matrl 16(3): 034603 
Warheit DB, Webb TR, Sayes CM, Colvin VL, Reed KL. (2006) Pulmonary instillation studies 
with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and 
surface area. Toxicol Sci 91(1):227-236 
Warheit DB, Webb TR, Colvin VL, Reed KL, Sayes CM. (2007) Pulmonary bioassay studies 
with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but 
on surface characteristics. Toxicol Sci 95(1):270-280 
Wehner AP, Dagle GE, Clark ML, Buschbom RL. (1986) Lung changes in rats following 
inhalation exposure to volcanic ash for two years. Environ Res 40:499-517 
Weichenthal SA, Godri-Pollitt K, Villeneuve PJ. (2013) PM2. 5, oxidant defence and 
cardiorespiratory health: a review. Environ Health 12(40):10-1186 
Wiester MJ, Setzer CJ, Barry BE, Mercer RR, Grady MA. (1985) Inhalation studies of Mt. 
St. Helens volcanic ash in animals: respiratory mechanics, airway reactivity and deposition. 
Environ Res 36:230-240 
World Health Organization. (2014) Accessed 20-April-2015 at: 
http://www.who.int/mediacentre/factsheets/fs313/en/ 
Wu S, Deng F, Wei H, et al. (2012) Chemical constituents of ambient particulate air pollution 
and biomarkers of inflammation, coagulation and homocysteine in healthy adults: A prospective 
panel study. Part Fibre Toxicol 9:49 
Yen AS, Gellert R, Schroder, et al.  (2005) An integrated view of the chemistry and mineralogy 
of Martian soils. Nature, 436(7047):49-54 
Yin F, Lawal A, Ricks J, Fox JR, Larson T, Navab M, Fogelman AM, Rosenfeld ME, Araujo JA. 
(2013) Diesel exhaust induces systemic lipid peroxidation and development of dysfunctional 
pro-oxidant and pro-inflammatory high-density lipoprotein. Arterioscler Thromb Vasc Biol 
33(6):1153-1161 
Young JW, Mattingly TK, Duke Jr CM.  (1972). Apollo 16 Technical Crew Debriefing NASA 
Johnson Space Center, Houston, TX, pp 10-17; 13-5 
Zhang J, Zhu T, Kipen H, et al. (2103) Cardiorespiratory biomarker responses in healthy young 
adults to drastic air quality changes surrounding the 2008 Beijing Olympics. Res Rep Health Eff 
Inst 174:5-1 
50	  
	  
X  TEAM 
Current Authors 
Robert R. Scully, Ph.D. Wyle 
Cell Biologist, member of the pulmonary toxicity assessment team. Together with 
CWL performed the inhalation studies, analyzed data of the inhalation and ITI 
studies and co-authored several publications from the pulmonary studies (lead 
author on one). Coordinated meetings of LADTAG and prepared reports of 
LADTAG meetings.  Together with JTJ and CWL presented evidence to support 
a recommendation for a PEL for episodic exposure to airborne lunar dust to 
extramural panel of expert toxicologists (EPET) that was convened by OCHMO 
to review the recommendation, and assisted VEM and TM with providing 
responses to EPET and formulating their final recommendation to OCMO for the 
PEL. 
Valerie E. Meyers, Ph.D.  NASA 
Toxicologist and lead investigator for studies of ocular effects of airborne lunar 
dust and coauthor of several publications resulting from the lunar dust toxicity 
studies (lead author on one), currently NASA’s lead toxicologist; principally 
responsible, in collaboration with Environmental Sciences Branch Chief, for 
responding to the recommendations of the EPET and formulating the final 
recommendation to OCHMO for the PEL for airborne lunar dust. 
Past Authors 
John T. James, Ph.D. NASA (Retired) 
Principle Investigator, LDTRP, responsible for leading and integrating the efforts 
of all research teams. Chaired meeting of LADTAG, co-authored several 
publications (lead author on one). Responsible for providing the recommendation 
of PEL for airborne lunar dust to EPET. 
Noreen Khan-Mayberry, Ph.D. NASA 
Toxicologist, in collaboration with JTJ, responsible for managing project during 
its early phases. 
Lunar Dust Pulmonary Toxicity Team 
Chiu-wing Lam, Ph.D. Wyle 
Toxicologist and pulmonary toxicity team lead, principally responsible for 
establishing the inhalation exposure laboratory at JSC. Performed ITI and 
inhalation studies, analyzed data and co-authored several publications from the 
studies (lead author on one). Together with JTJ and RRS presented evidence to 
51	  
	  
support a recommendation for a PEL for episodic exposure to airborne lunar dust 
to EPET and assisted VEM and Environmental Sciences Branch Chief with 
providing responses to EPET and formulation of final recommendation to 
OCHMO for PEL. 
Stephanie Bassett, Wyle 
Animal Care Facility Manager, responsible for providing care for all experimental 
animals. Assisted in collection of tissue samples. 
Geology Team  
David S. McKay, Ph.D. NASA (Deceased) 
Geologist and team lead, primarily responsible for providing the respiratory size 
lunar dust needed for the toxicity studies. Performed particle size distribution and 
other physical characterizations of the lunar dust, lead author of a publication that 
describes physicochemical properties of respirable-size lunar dust. 
Bonnie Cooper, Ph.D. Oceaneering (now Hanyang University, South Korea) 
Geologist, principally responsible for the development of new techniques that 
allowed respirable sized dust particles to be separated from the bulk sample by a 
dry method, which insured that the properties of the dust would not be affected by 
the isolation method. Coauthor of publication that resulted from these efforts. 
Dermal Toxicity/Cell Biology Team 
David Loftus, M.D. Ph.D., NASA 
Performed preliminary dermal abrasion studies with lunar dust and together with 
JR performed functional assessments of cells obtained from lungs of animals 
exposed to lunar dust 
John Rask, NASA 
Performed, with DL, functional assessments of cells obtained from lungs of 
animals exposed to lunar dust 
Chemistry Team  
Antony Jeevarajan, Ph.D., NASA 
Physical Chemist, former Chemistry team Lead, current Deputy Chief of the 
Biomedical Research and Environmental Sciences Division, coauthor of 
publications that describe activation of lunar dust simulants and authentic lunar 
dust, and characterization of nanophase iron-enhanced chemical reactivity of 
ground lunar dust. 
52	  
	  
William T. Wallace, Ph.D.  Wyle 
Physical Chemist – Surface Chemistry, performed activation and dissolution 
physiochemical characteristics of lunar dust.  
Molecular Biology Team 
Ye Zhang, Ph.D. Wyle 
Molecular Biologist, NASA Core Lab Lead, performed studies to profile gene 
expression in lungs of rats exposed to lunar dust, principle author of publications 
that are in preparation. 
Pathologists 
Roger Renne, D.V.M., ToxPath Consulting Inc 
Richard A. McCluskey, M.D., Naval Hospital Pensacola, Pensacola, FL 
Final Recommendation for PEL 
Torin McCoy, NASA 
Toxicologist, Chief of NASA’s Environmental Sciences Branch, together with 
VEM principally responsible for providing response to the recommendations of 
the EPET and formulating the final recommendation to OCHMO for the PEL for 
airborne lunar dust. 
Lunar Airborne Dust Toxicity Assessment Group – Non NASA Members 
Vince Castranova, Ph.D, NIOSH (now University of West Virginia), Toxicologist 
Bean Chen, Ph.D, NIOSH, Toxicologist 
Kevin Driscoll, Ph.D., Proctor and Gamble, Toxicologist 
Don Gardner, Ph.D. (Deceased), Independent Inhalation Toxicologist 
Robert Hunter, M.D., Univ. Texas Health Science Center at Houston, Pathologist 
Roger McClellan, Ph.D. Independent Toxicologist 
Harrison Schmidt Ph.D. Geologist NASA Apollo 17 crewmember. 
Larry Taylor, Ph.D. University of Tennessee, Lunar Geologist 
  
53	  
	  
XI  ACRONYMS 
BALF Bronchoalveolar Lavage Fluid 
BMD Benchmark Dose 
CDNPs Combustion-derived Nanoparticles 
CM Command Module 
CNS Central Nervous System 
CS Crystalline Silica 
CV Cardiovascular 
DEP Diesel Exhaust Particle 
ECLSS Environmental Control Life Support System 
EPA Environmental Protection Agency 
EVA Extravehicular activities 
Fe0 Nanophase metallic iron 
GI Gastrointestinal 
HEPA High Efficiency Particulate Air 
HRP Human Research Program 
ICR Imprinting Control Region 
IPI Intrapharyngeal instillation 
IRAC International Agency for Research on Cancer 
ITI Intratracheal Instillation 
JSC Johnson Space Center 
LADTAG Lunar Airborne Dust Toxicology Assessment Group 
LDTRP Lunar Dust Toxicity Research Portfolio 
LM Lunar Module 
LMP Lunar Module Pilot 
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NASA National Aeronautic and Space Administration 
NO Nitric Oxide 
NOAEL No-Observable-Adverse-Effect Level 
NP Nanoparticle 
npOx anophase iron oxides 
NRC National Research Council 
O2  Superoxide anion 
ONOO- Peroxynitrite 
OCHMO Office of Chief Health and Medical Officer 
OR Oxidative Reactivity 
PEL Permissible Exposure Limit 
PM Particulate Matter 
PMN Polymorphonuclear leukocytes (neutrophils) 
PVPNO Polyvinylpyridine-N-oxide 
RNA Ribonucleic Acid 
RNS Reactive Nitrogen Species 
ROS Reactive Oxygen Species 
SEM Scanning Electron Microscope 
SHFH Space Human Factors and Habitability Element 
TIM Technical Interchange Meeting 
TiO2 Titanium dioxide 
UFP Ultrafine particle 
µm Micron 
 
 
